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Abstract 
 
The cyathins are a unique group of diterpenoids produced by the bird’s nest 
fungi Cyathus helenae, C. africanus, and C. earlei. Several of the cyathins 
show strong antibiotic activity. More recently, several fungal metabolites 
with structures closely related to those of the cyathins have been found to 
be potent inducers of nerve growth factor (NGF) synthesis. The structural 
complexity and the exciting biological activity of the cyathane family of 
diterpenes have prompted our efforts to develop an efficient and general 
synthetic approach. 
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To date, there have been seven total syntheses and six partial syntheses of 
cyathins. Most of these syntheses target allocyathin B2, which does not 
contain the common 6-7 trans ring fusion or the hydroxyl group within the 
seven member ring. Modifications of these routes to provide targets with 
these features have not been demonstrated and may be challenging. We 
have developed a concise asymmetric synthesis of cyathin A3, based on the 
enantioselective Diels-Alder reaction of quinone (106) and diene (105). 
Because the transformations of cyathin A3 into other cyathins are well 
documented, this synthesis provides a general approach to the cyathane 
diterpene family.  
In Section 2.2, the enantioselective Diels-Alder reaction of quinone 106 and 
diene 105 is presented. This reaction is effectively catalyzed by a carefully 
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prepared Mikami catalyst. It was carried out on a preparative scale to give 
the chiral building block 108. The absolute configuration of the Diels-Alder 
adduct 108 was determined by NMR and X-ray analysis. 
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In Sections 2.3-5, the enantioselective total synthesis of (-)-cyathin A3 is 
described. This approach features the successful oxymercuration ring 
opening, a newly developed in situ configuration inversion, a much 
improved intramolecular aldol reaction and a radical cyclization. Now 
envisioned in our laboratory is the development of a new access to cyathin 
A4 (5), which is surmised to be possible via the intermediate prepared in this 
synthesis (e.g., 128).  
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1. Introduction 
The cyathins are a unique group of diterpenoids produced by the bird’s nest 
fungi Cyathus helenae, C. africanus, and C. earlei. Ayer and co-workers 
isolated the first natural product of this class in 1971 and several additional 
members of the family were discovered throughout the 1970’s.1-8 Several of 
the cyathins, especially cyathin B3 and cyathin C3, show strong antibiotic 
activity.1,7  
More recently, several fungal metabolites with structures closely related to 
those of the cyathins have been reported. Kawagishi9-11 isolated the 
analogous erinacines from Hericium erinaceum. The scabronines12-14 and 
sarcodonins15 have been isolated from Sarcodon scabrosus. Many of these 
recently discovered compounds have been shown to be potent stimulators 
of nerve growth factor (NGF) in vitro.9-14 
1.1 Isolation and structure of the cyathanes 
All of the cyathin diterpenoids were determined to possess a twenty-carbon 
skeleton containing a 5-6-7 fused tricyclic core, with the numbering scheme 
shown in Figure 1.  
The isolated C20 compounds with 30 hydrogen atoms are classified as 
cyathin A derivatives. Those with 28 hydrogens are cyathin B derivatives 
and those with 26 hydrogens are members of the cyathin C class. The 
number of oxygen atoms is given by the subscript; thus, cyathin A3 (1) is 
C20H30O3. The prefixes allo- and neoallo- denote structural isomers of the 
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cyathin initially isolated.  
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917
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1314
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Figure 1. Cyathane numbering system 
 
1.1.1 Isolation and structure of the cyathins 
Cyathins were extracted from the culture broth of Cyathus helenae, a new 
species first discovered in the Canadian Rockies. 1  
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Figure 2. Structures of the cyathin diterpenes 
 
Nine novel diterpenoids2-8 (cyathin A3, cyathin A4 and allocyathin A4, 
neoallocyathin A4, cyathin B3, cyathin B4, cyathin C5, allocyathin B3, and 
cyathin C3) were isolated and characterized. Cyathin A3 is the major 
metabolite produced among these nine diterpenoids. The stereochemistry 
and absolute configuration of cyathin A3 and allocyathin B3 were 
established by X-ray crystallography and the structures of other cyathins 
(e.g 10 and 11) were confirmed by chemical correlation with these known 
compounds or known derivatives thereof (Figure 2). 
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Figure 3. Structures of the cyafrin diterpenes 
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Cyathus africanus, a new species of the genus Cyathus from the area of 
Mount Kilimanjaro, Tanzania, was discovered by D. Hocking.16 The ethyl 
acetate extract of the cultured broth of C. africanus provided six cyathin 
diterpenoids (cyathin A3, allocyathin B3, cyafrin A4, cyafrin B4, allocyafrin B4, 
and cyafrin A5) (Figure 3). 
The structure of cyafrin A4 (12) was confirmed by dehydration of the C-1 
hydroxy group to give allocyathin B3 (3), and the structure of cyafrin A5 (13) 
was confirmed through epoxidation of cyafrin A4 (12). Allocyafrin B4 (15) 
was prepared from cyafrin A4 (12) via oxidation followed by rearrangement 
of the double bond into conjugation in methanolic HCl.   
1.1.2 Isolation and structure of the erinacines and striatins 
Erinacines9-11,17 were isolated from Hericium erinaceum and striatins were 
isolated from the mycelium of the basidiomycete C. striatus strain No.12. 
Erinacines and striatins16 are glycosylated cyathins. These compounds are 
essentially comprised of a D-xylose moiety anchored onto the cyathin 
framework (Figure 4).  
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Figure 4. Structures of erinacines A-F 
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Figure 5. Structures of erinacines P and Q and striatal A 
1.1.3 Isolation and structure of the sarcodonins and 
scabronines 
Sarcodonins18,19 and scabronines 12-14 are two families of diterpenes closely 
related to cyathins, that were isolated from the mushroom Sarcodon 
scarbrosus. The major difference between these compounds and the 
cyathins is the oxidation state of C20 in the sarcodonins (Figure 5) and C17 
in the scabronines (Figure 6).  
 
HO
CHO
OH
O
CHO
OH
H
25 sarcodonin A 26 sarcodonin G  
Figure 6. Structures of the sarcodonins 
 
Although there have been eight sarcodonins discovered (sarcodonins A-H), 
only the structures of sarcodonin A and G have been established. 15 
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Figure 7. Structures of the scabronines. 
 
1.2 Biological activities of the cyathanes 
Allocyathin B3 and cyathin C3 exhibited antibiotic activity against Gram 
positive and Gram negative bacteria as well as actinomycetes. A renewed 
interest in this class of natural products was initiated by the discovery that 
members of the erinacine and scabronines class stimulate the biosynthesis 
of nerve growth factor (NGF).9-13,17,20-24  
In a bioassay using mouse astroglial cells in the presence of erinacines A, B, 
and C, the amounts of NGF detected in the culture medium were four fold, 
two fold, and five fold higher than in the presence of epinephrine, a known 
potent NGF stimulator used as a positive control-compound in the assay. 
Moreover, erinacine E was recently shown to not only have potent NGF 
synthesis-stimulating activity, but also κ-opioid receptor agonist activity.11 
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1.3 Synthetic transformations of the cyathanes 
1.3.1 Transformation of cyathin A3 into cyathin B3, 
allocyathin B2 and neoallocyathin A4  
Cyathin A3 was the most abundant metabolite isolated from Cyathus 
helenae and from Cyathus africanus. The transformation of cyathin A3 into 
other cyathins was, therefore, of interest.  
 
Scheme 1 
O
CH2OH
H OH
1 cyathin A3
O
CHO
H OH
2 cyathin B3
a
O
CHO
b
c, a
HO
CHO
10 allocyathin B2
34
 
 
(a) MnO2; (b) Ac2O, Py; (c) LiAlH4. 
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Scheme 2 
O
CH2OH
H OH
7 neoallocyathin A4
O
O
CH2OAc
H OAc
ba
c
O
CH2OAc
H OAcO
35
36
O
CH2OH
H OH
1 cyathin A3
 
(a) Ac2O, Py; (b) m-CPBA; (c) K2CO3 
 
Selective oxidation of cyathin A3 with manganese dioxide in ether provided 
cyathin B3. Treatment of cyathin B3 with pyridine and acetic anhydride gave 
both cyathin B3 acetate and triene 34. Allocyathin B2 was easily prepared by 
reducing triene 34 with LiAlH4. Epoxidation of cyathine A3 acetate followed 
by deprotection yielded neoallocyathin A4.7 
 
1.3.2 Transformation of cyathin A3 into allocyathin B3 and 
cyathin C3 
The key step in the transformation of cyathin A3 into allocyathin B3 involved 
the formation of bromodiene 38 by treatment of the protected cyathin A3 
derivative 37 with NBS in the presence of benzoyl peroxide. Sequential 
dehalogenation and deprotection furnished allocyathin B3 (3). Alternatively, 
cyathin C3 (4) could be similarly obtained by careful oxidation of the 
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hydroxyl group in 39 and hydrolysis (Scheme 3). 
 
Scheme 3 
OMe
O
H
OH
OHH
OH
O
3 allocyathin B3
c
d
OHH
O
4 cyathin C3
CHO
OHH
OH
O OMe
O
H
OAc
a b
OMe
O
H
OAc
Br
e
d
1 cyathin A3 37
38
39  
(a) i, MeOH, HCl; ii, Ac2O, Py; (b) 2eq NBS, CCl4, (Bz)2O2 Δ; (c) LiAlH(OCH3)3, CuI, THF; 
(d) H3O+; (e) MnO2, Et2O;  
 
1.3.3 Transformation of cyafrin A4 into allocyathin B3 methyl 
ketal and allocyafrin B4 methyl ketal 
In order to correlate cyafrin A4 (12) with allocyathin B3 (3), the C-1 hydroxy 
group was mesylated after protection the two hydroxyl groups on the C-ring 
as an acetonide (Scheme 4). Treatment of the resulting mesylate 41 with 
DBU did not promote elimination but led to the deconjugated ketone 43. 
After transformation of 41 into methyl acetal 42, prolonged refluxing with 
DBU provided the desired A-ring diene 39, which was identical to the one 
prepared alternatively from allocyathin B3 (3) by treatment with methanolic 
HCl. 
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Scheme 4 
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H OH
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H
O
HO
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a
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(a) MsCl, Py; (b) CH3OH, HCl; (c) DBU, dioxane, Δ; (d) DBU, toluene, Δ 45h. 
Alternatively, acetonide 40 was oxidized to ketone 44, which gave 
allocyafrin B4 methyl acetal 45 after isomerization of the double bond to the 
C-2,3 position (Scheme 5). 
Scheme 5 
O
CH2OH
H OH
HO
12 cyafrin A4
a
O
H O
HO O
O
H O
O O
b
O
H OH
O
15 allocyafrin B4
OMe
H
O OH
O
c
c
40
4544
OH
 
 (a) (CH3)2C(OCH3)2, p-TsOH, r.t.; (b) Jones’ oxidation; (c) CH3OH, HCl. 
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1.4 Synthetic studies on cyathanes 
From a synthetic point of view, the key structural features of cyathanes 
include: the 5-6-7 tricyclic ring system, the anti-1,4 methyl groups at 
quaternary carbons C6 and C9, the extensive oxygenation on ring–C, and 
the trans 6-7 ring fusion.  
To date, there have been seven total syntheses and six partial syntheses of 
cyathins. Most of these syntheses target allocyathin B2 (10), which does not 
contain the common 6-7 trans ring fusion, or the hydroxyl group at carbon 
11. Modifications of these routes to provide targets with these features have 
not been demonstrated and may be challenging.  
 
1.4.1 Snider’s synthesis 
Snider25,26 was able to achieve the first total synthesis of racemic 
allocyathin B2 and (+)-erinacine A (16) (Scheme 6).  
 
Scheme 6 
OH
CHO
10 allocyathin B2
OH
CH2H
O
CH3H
O
O
47 48
4950  
 
Snider adopted a linear synthetic sequence that involved consecutive 
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assembly of the A, B and C rings. The key step involved a Me2AlCl initiated 
intramolecular carbonyl-ene cyclization.27 Snider envisioned that the 
alcohol 47 was an advanced intermediate for the synthesis of allocyathin B2, 
which could be obtained from aldehyde 48. The ene substrate was 
designed from enal 49, which would be derived from readily available 50.28  
 
 
Scheme 7 
O R
R
O
CH2
OR
CH2H
OH
OH
O
RH
51 R=OTf
52 R=CO2Me
53 R=CH2OH
49 R=CHO
b
c
d
e,fa
g
i,j,kl,m
57 R=OTf
58 R=CO2Me
n
47 R=H
55 R=Si(i-Pr)Me2
h
50 54 R=H
48 R=Me
56
 
 
(a) Proton Sponge, Tf2O, 88%;  (b) Pd(OAc)2, Ph3P, CO, i-Pr2EtN, 85%;  (c) DIBAL, 97%;  
(d) MnO2, 95%;  (e) H2CC(CH3)(CH2)2MgBr, CuBrDMS, TMSCl, 91%;  (f) tBuOK, MeI, 
75%;  (g) Me2AlCl, 87%;  (h) i-Pr(Me)2SiCl, imid., 95%;  (i) OsO4, KIO4, 77%;  (j) 
LHMDS, PhSeCl, H2O2, 72%;  (k) AcOH, H2O;  (l) Dess-Martin, 72% 4 steps;  (m) 
KHMDS, PhNTf2, 75%;  (n) Pd(OAc)2, Ph3P, CO, iPr2EtN, 75%. 
 
The synthetic approach commenced with palladium-catalyzed 
carbonylation of the enol triflate 51 (Scheme 7), which was readily prepared 
from the previously reported enone 50 (available in 2 steps). The resulting 
dienoate 52 was reduced and reoxidized to give aldehyde 49. 
Copper(I)-catalyzed conjugate addition of pentenyl magnesium bromide to 
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49 gave 54 as a mixture of epimers at C6.29 The stereoselectivity of the 
cuprate addition was unfortunate because the incorrect stereochemistry 
was generated at C5.30-32 However, subsequent methylation of 54 provided 
the desired product 48 as a prelude to C-ring closure. The intramolecular 
carbonyl ene reaction proceeded readily to form the C13-C14 bond and 
give the alcohol 47 containing the complete cyathane skeleton but with a cis 
B-C ring fusion. Oxidative cleavage of the exocyclic methylene in 47 was 
followed by conversion to the enone 56 by a selenation-elimination 
sequence after alcohol deprotection. Alcohol 56 was oxidized and the 
resulting β-diketone was converted selectively to the enol triflate 57 upon 
treatment with N-phenyltriflimide. Installation of the remaining carbon of the 
cyathin system was accomplished via palladium-catalyzed carbonylation to 
provide the methyl ester 58 in good yield. 
 
Scheme 8 
O
CO2MeH
O
CO2Me
OH
CHO
10 allocyathin B2
O
R
O
RO
OR
OR
O
R
O
RO
OR
OR
60 R=Ac
16 R=H, erinacine A e
61 R=Ac
62 R=H e
58 59
a b,c
d d
 
(a) Et3N, MeOH, 94%;  (b) LAH, 89%;  (c) MnO2, 94%;  (d) triacetyl-a-D-xylopyranosyl 
bromide, Hg(CN)2, HgCl2, 34%;  (e) K2CO3, MeOH, >90%.  
 
With key intermediate 58 in hand, the stage was set for the final 
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manipulation of the peripheral functionality to complete the total synthesis 
(Scheme 8). Isomerization of 58 under basic conditions gave the 
non-conjugated ketone 59 and removed the undesired stereochemical 
arrangement at C5. Global reduction of 59 was followed by selective 
oxidation of the allylic alcohol to give racemic allocyathin B2 (10). 
Glycosylation of racemic 10 with α-bromo-2,3,4-tri-O-acetyl-D-xylopyranose 
provided erinacine A triacetate (60) and the diastereomer 61. The two 
diastereomers were separated and deprotected to give erinacine A (16) and 
62, respectively. This synthetic approach delivered 10 and 16 in 17 and 19 
steps, respectively. 
 
1.4.2 Tori’s synthesis 
The general features of Tori’s33 synthesis of racemic allocyathin B2 are 
summarized in Scheme 9. Tori’s synthetic strategy involved the 
construction of both the A ring and the C ring via two aldol cyclizations. The 
assembly of the highly functionalized seven-member ring was deferred to 
the last stage in the synthesis.  
Scheme 9 
OH
CHO
10 allocyathin B2
CHO
OH
CHO
O
O
OR
64 R=TBDPS
O
O
63
6566  
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The synthetic objective became 63 and it was anticipated that this 
substance could be derived from intermediate 64 through a straightforward 
sequence of reactions. Removal of the side chain appendages from lactone 
64, the projected precursor of dialdehyde 63, reveals hydrindenone 65, 
which could be derived from 3-methylcyclohexenone.  
Tori began the synthesis by conversion of readily available 
3-methylcyclohexenone (66) in 5 steps to diketone 70 (Scheme 10). 
Treatment of diketone 70 with base followed by dehydration generated the 
desired hydrindenone 65.  
Scheme 10 
O O
O O
HO
O O
O
O
O
a b
c,d
ef
66 67 68
697065  
 
(a) CH2CHCH2CH2MgBr, CuBrDMS, THF;  (b) HOCH2CH2OH, TsOH, PhH, 88% 2 steps; 
(c) O3, Zn, AcOH;  (d) i-PrMgBr, 83%;  (e) Jones oxidation;  (f) 5%-KOH, MeOH, 73% 2 
steps. 
The stage was then set for stereoselective addition of the methyl group and 
the side chain.  The initial assumption was that alkylation of 65 at the C-11 
position would occur from the convex face of the ring, which turned out to 
be wrong. Methylation of 65 followed by aldol condensation with the four 
carbon aldehyde34 gave the wrong stereoisomer and eventually led to 
isoallocyathin B2 (72) (Scheme 11).35 After considerable experimentation, it 
was discovered that the desired diketone 75 could be prepared by 
methylation of diketone 74, the product of C-acylation of ketone 65.   
 16
 
Scheme 11 
O O
OH
OTHP
O
O
OTBDPS
a,b
c
OH
CHO
72 isoallocyathin B265 71
73 (60%)
O
O O
O
OTBDPS
+
74 (37%)
OTBDPS
d
75  
 
(a) LDA, MeI, THF; (b) LDA, THF, HCO(CH2)3OTHP, 20%;  (c) LDA, THF 
ClCO(CH2)3OTBDPS, -78°C, 37%; (d) tBuOK, MeI, 91%. 
 
Diketone 75 was regioselectively and stereoselectively reduced with zinc 
borohydride to afford 76,36 which was converted to the corresponding 
acetate 77 (Scheme 12). Intramolecular aldol reaction of 77, followed by 
dehydration with thionyl chloride provided the unsaturated lactone 78. The 
lactone 78 was reduced with LiAlH4 to give the triol 79. After protecting 
group manipulations, diol 82 was oxidized to the corresponding dialdehyde 
83 via Swern oxidation. Intramolecular aldol cyclization of 83 completed the 
total synthesis of racemic allocyathin B2 in 18 steps. 
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Scheme 12 
O
O
OTBDPS O
OR
OTBDPS
O
O
OTBDPS
OR2
OR1
OR1
CHO
OAc
CHO
OH
CHO
a c,d
e
i
j
79 R1=H, R2=H
80 R1=TBS, R2=H
81 R1=TBS, R2=H
82 R1=H, R2=Ac
f
g
h
76 R=H
77 R=Ac
b75
78
83 10 allocyathin B2  
 
(a) Zn(BH)4, Et2O, -78°C;  (b) Ac2O, DMAP, pyridine;  (c) LHMDS, THF, -78°C;  (d) 
SOCl2, pyridine, DCM;  (e) LAH;  (f) TBSCl, Et3N, 37% 2 steps;  (g) Ac2O, DMAP, Py;  
(h) PPTS, MeOH, 52%, 2 steps;  (i) Swern;  (j) 5%-KOH MeOH, 74%, 2 steps. 
 
1.4.3 Piers’ synthesis 
Piers’37 synthetic target was sarcodonin G, a highly functionalized member 
of the cyathane family of diterpenoids, that contains a trans-fused B-C ring 
system. The general features of Piers’ synthesis are outlined 
retrosynthetically in Scheme 13. The key steps involved the stereoselective 
cyclization of iodoketone 86, Still-Mitra [2,3]-sigmatropic rearrangement38 to 
generate allylic alcohol 85, and the SmI2-induced ring expansion of 
α-iodomethylketone 84 to provide the cyathane carbon skeleton. 
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Scheme 13 
O
HO
I
CH2OH
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CO2Et
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CH2OH
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26 sarcodonin G 84 85
86 87
OR
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Piers’ synthesis started with the known mixture (trans:cis ~3.5:1) of 
decalones 87, that were converted to the corresponding mixture of 
dimethylhydrazones 88 (trans:cis ~1:1) (Scheme 14). CSA-catalyzed 
equilibration of 88 followed by chromatography provided the trans-fused 
dimethylhydrazone 89. Alkylation of the anion of 89 with iodide 90 gave 
hydrazone 91.39,40 The iodide 90 was prepared from ethyl pent-2-ynoate via 
germylation,41 deconjugation,42 reduction, and iodination in six steps. After 
hydrolysis of the hydrazone 89, the resulting ketone 92 was first treated with 
sodium methoxide to isomerize the side chain to the equatorial position and 
then a methyl group was stereoselectively added by alkylation of the 
corresponding enolate to obtain 93. Thus, the anti relationship between 
methyl groups at C9 and C6 was established.  
Subjecting alkenyltrimethylgermane 93 to NIS provided the iodo-alkene 
86.43 Metal-halogen exchange on 86 triggered an intramolecular addition to 
the carbonyl, which furnished the tricyclic alcohol 94.44 Sequential treatment 
of the tertiary allylic alcohol 94 with KH and tributylstannylmethyl iodide 
generated α-stannyl ether 95. Lithiation of 95 followed by Still-Mitra 
[2,3]-sigmatropic rearrangement to 85 stereoselectively introduced the 
hydroxmethyl group and established the C3-C4 olefin in one operation.38,45 
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Scheme 14 
Me3Ge
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R
OR
CH2OH
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87 R=O
88 R=NNMe2
a
91 R=NNMe2
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93 R=GeMe3
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(a) Me2NNH2, CSA, 82%;  (b) CSA, PhH, reflux;  (c) KDA, DMPU, 90;  (d) HOAc, 
NaOAc, 69% 3 steps; (e) NaOMe, MeOH, 82%;  (f) LiNEt2, CH3I, 85%;  (g) NIS, CH2Cl2, 
90%;  (h) BuLi, 86%;  (i) KH, 18-Crown-6, Bu3SnCH2I;  (j) BuLi, 88% 2 steps. 
 
With key intermediate 85 in hand, the stage was set for the final expansion 
of ring C and installation of the required peripheral functionality (Scheme 
15). Protection of the primary alcohol in 85 as a PMB ether and 
chemoselective oxidative cleavage of the exocyclic double bond provided 
ketone 97. Ethoxycarbonylation of 97 followed by alkylation with 
diiodomethane gave a diastereomeric mixture of iodomethyl keto-esters 84. 
Subjecting 84 to samarium(II) iodide initiated a one carbon ring expansion35 
providing cycloheptanone 99. Sequential reduction and oxidation of 99 
gave keto-aldehyde 100. Treatment of 100 with piperidine, followed by 
PhSeCl, gave a diasteromeric mixture of selenides that, on oxidation, 
produced a regioisomeric mixture of alkenes that isomerized to enal 101 
under basic conditions. Removal of the PMB group in 101 with DDQ 
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completed the total synthesis of racemic sarcodonin G (26) in 21 steps from 
decalin 87. 
Scheme 15 
X
CH2OR
OH
CH2OPMB
CO2Et
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CH2OPMB
CO2Et
I
O
CH2OPMB
CO2Et
O
CH2OPMB
CHO
O
CH2OR
CHO
101 R=PMB
26 R=H
k
c d
e
f,gh,i,j
85 R=H, X=CH2
96 R=PMB, X=CH2
97 R=PMB, X=O
a
b
98 84
99100  
(a) KH, PMBCl, TBAI, 96%;  (b) OsO4, KIO4, 85%;  (c) KH, NaH, (EtO)2CO, 74%;  (d) 
TBAF, CH2I2, 78%; (e) SmI2, 71%;  (f) DIBAL-H;  (g) Dess-Martin, 86% for 2 steps;  (h) 
piperidine, PhH then PhSeCl;  (i) KIO4, 78% for 2 steps;  (j) DBN, PhH, 95%;  (k) DDQ, 
H2O, 91%. 
 
1.4.4 Ward’s synthesis 
The first published synthetic approach to cyathins was developed by Ayer 
and Ward, which provided a key 5-6-6 tricyclic intermediate.46 Ward 
extended this work and was able to accomplish the total synthesis of 
racemic allocyathin B3.47 Ward’s synthesis was the first general route 
providing both the trans 6-7 ring fusion and the fully functionalized 
seven-membered ring, that with simple modifications might be applied to 
the synthesis of any of the known cyathin diterpenes, as well as several 
related natural products.  
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The general features of Ward’s synthesis are outlined retrosynthetically in 
Scheme 16. The key steps involved [2+2] cycloaddition followed by 
intramolecular aldol addition to form the A-ring; [4+2] cycloaddition followed 
by ring expansion to form the C-ring and intramolecular radical cyclization 
to introduce the isopropyl group. 
Ward’s synthesis commenced with the Diels-Alder reaction of 
2,5-dimethylbenzoquinone 10648,49 with diene 105 (a 1:1 mixture of 
diastereomers)50 to yield the adduct 108 as a single stereoisomer (Scheme 
17). Photochemical [2+2] addition of 108 to allene provided a 4 : 1 mixture 
of regioisomeric methylene cyclobutanes 109 and 110 with the desired 110 
as the major product. Thus installation of the anti methyl groups at C-6 and 
C-9 was accomplished in two steps. The relative stereochemistry was 
controlled by the face selectivity of the sequential cycloadditions. 
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(a) 140°C (92%); (b) i. allene, hν; ii. TFA; (c) i. m-CPBA; ii. 9-BBN; iii. PhSH, NaOH (50% 
from 108); (d) PhCOOH, DEAD, Ph3P; (e) NaBH4, CH2Cl2, MeOH, -78°C; (f) i. NaOH, 
MeOH; ii. RaNi; (g) NaOH, MeOH, reflux; (h) BzCl, Et3N, DMAP (60% from 111).  
 
Epoxidation of the hydrolyzed photoadducts 109 and 110 followed by 
selective 1,2 reduction of the enone and fragmentation of the epoxide with 
thiophenol under basic conditions formed cyclopentenone 111 in one 
operation. The hydroxyl group at C11 was inverted under Mitsunobo 
conditions to yield 112. Chemoselective reduction51 of dione 112 gave 113. 
After hydrolysis of the benzoate in 113, desulfurization with Raney nickel 
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furnished the enone 114. Treatment of 114 with sodium hydroxide 
successfully isomerized the cis-ring fusion to the trans-ring fusion to provide 
115. Chemoselective benzoylation of diol 115 gave key intermediate 116.  
Scheme 18 
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(a) MsCl, pyridine, 50°C (93%); (b) DBU, toluene reflux (75%); (c) H2, RhCl(Ph3P)3 (90%); 
(d) O3, Sudan III, then Me2S; (e) TsOH, toluene; (f) MeI, Ag2O (50% from 104). 
 
Removal of the now unwanted hydroxyl group at C7 in 116 was achieved by 
mesylation followed by elimination of the mesylate and chemoselective 
reduction of the resulting olefin to provide 104 (Scheme 18). The next stage 
in the synthetic sequence involved expansion of six-membered ring to 
furnish the required seven-membered C-ring system. Selective ozonolysis 
of the non-conjugated double bond in 104 was achieved by ozonolysis in 
the presence of Sudan(III)52 as an indicator. Treatment of the resulting 
keto-aldehyde 121 with acid triggered the sequential aldol condensation 
and benzoyl group migration. After methylation of the hemiacetal, the key 
intermediate 103 was obtained, containing the complete 5-6-7 cyathane 
ring system with correct relative stereochemical configuration at all 
positions. 
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Scheme 19 
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(a) MeOH, HCl, (MeO)3CH, toluene, reflux; (b) NBS, propargyl alcohol, CH2Cl2, -78°C; (c) 
Ph3SnH, AIBN, C6H6, reflux (60% from 103); (d) H2, Pd-C, EtOAc (90%). (e) TMSCl, NaI. 
 
Strategies to introduce the isopropyl group at C-3 of 103 were not obvious. 
After considerable experimentation, a method was established to introduce 
a 3-carbon side chain based on radical cyclization (Scheme 19). Treatment 
of 103 with trimethyl orthoformate and methanolic HCl in toluene followed 
by azeotropic distillation of MeOH produced dienol ether 124. 
Cohalogenation53 of 124 with NBS and propargyl alcohol gave the 
somewhat unstable 125 as a single diastereomer, which cyclized54 to 126 
on treatment with Ph3SnH and AIBN in refluxing benzene. Unmasking the 
isopropyl group present in 126 proved to be difficult. Because of the facile 
formation of 128 from 126, efforts were directed at unraveling the reduced 
derivative 127, easily repared by hydrogenation of 126. 
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(a) PPTS, acetone, H2O, rt, 12 day (75%; quantitative based on conversion). 
 
Exposure of 127 to 10% aq. HCl in THF slowly (ca. 14 h) produced the 
isomerized hemiacetal 131 without evidence of an intermediate (Scheme 
20) (by TLC monitoring). Unfortunately, all attempts to trap the hydroxy 
ketone tautomer of hemiacetal 131 failed.  
A serendipitous observation was crucial to the successful synthesis 
(Scheme 20). On one occasion, hydrogenation of 126 under the usual 
conditions unexpectedly gave 128 (25%) along with 127. In contrast to 131, 
128 was a 1.5:1 mixture (by NMR in CDCl3 solution) of the hydroxy ketone 
(128a) and hemiacetal (128b) tautomers, respectively. Importantly, esters 
of the hydroxy ketone tautomer 128a could be prepared in good yield. A 
more detailed investigation of the hydrolysis of 127 was undertaken. On 
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standing in CDCl3 solution, 127 quantitatively isomerized into 132 within 3 
days (presumably catalyzed by adventitious HCl); molecular mechanicsa 
indicated that 132 was 2.1 kcal/mol more stable than 127 largely due to the 
decreased steric interaction between the C-11 methyl group with H2C-1 in 
the former. Hydrolysis of 132 (10% aq. HCl in THF, 14 days) also gave 131 
but much more slowly than hydrolysis of 127 (14 h) under the same 
conditions.  
Scheme 21 
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(a) i. Ph2PCl, pyridine, toluene. ii. I2; (b) H2, Pd-C (65% from 128); (c) i. NaOH, MeOH, 
reflux; ii. NMO, TPAP (85%); (d) i. Tf2O, 2,6-di tert-butyl-4-methylpyridine; ii. Bu3SnH, LiCl, 
Pd(Ph3P)4, THF (50%); (e) i. NaN(TMS)2, THF, -78°C; ii. PhNTf2; iii. CO, DIEA, Pd(Ph3P)4, 
THF (50%); (f) DIBAL-H (50%); (g) 1 N HClO4, THF (80%). 
 
Exposure of 127 to DCl in CD3OD solution gave 130 at the same rate as the 
loss of 127 suggesting the formation of 129 as an intermediate (Scheme 
20). The formation of 130 indicated that hydrolysis of 127 without  
 
a CaChe version 3.9. 
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isomerization to 131 might be possible. After considerable experimentation, 
it was found that reaction of 127 with pyridinium 4-methylbenzenesulfonate 
(PPTS) in aqueous acetone for 12 days gave 128 (80%) along with 
recovered 127 (15%) (Scheme 20). The key intermediate 128 has a 
functionality that could potentially provide access to any of the various 
oxidation patterns present on the ring-A of cyathin and related diterpenes. 
The remainder of the synthesis was done on a small scale without 
optimization of the reaction conditions. Deoxygenation55 of the C-19 alcohol 
group was accomplished by reaction of 128 with Ph2PCl followed by I2 and 
reduction of resulting iodide 140 with H2 over Pd-C to give 141 (Scheme 
21). Treatment of 141 with NaOH in MeOH served to hydrolyze the 
benzoate ester with concomitant isomerization of the C-4,5 double bond 
into the required conjugated position. This isomerization reestablished the 
desired trans 6-7 ring fusion. The resulting alcohol was directly oxidized to 
ketone 102 with NMO and TPAP.56 Selective deoxygenation of the 
cyclopentenone carbonyl was achieved by reaction of 102 with triflic 
anhydride in the presence of a hindered base to give the dienol triflate,57 
which was reduced58,59 to cyclopentadiene 142 by Pd-catalyzed reduction 
with Bu3SnH. Finally, introduction of the vinyl hydroxymethyl group was 
achieved by Pd-catalyzed carbonylation60 of the vinyl triflate derived from 
142 followed by DIBAL-H reduction of the resulting ester 143 to give 39. 
Hydrolysis of 39 to racemic allocyathin B3 (a mixture of hydroxy ketone and 
hemiacetal tautomers) proceeded readily in THF solution on exposure to 
aqueous HClO4. 
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1.4.5 Nakada’s synthesis 
Scheme 22 
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Nakada61 recently reported the total synthesis of (+)-allocyathin B2, the first 
enantioselective synthesis of a cyathane diterpene. The general features of 
Nakada’s synthesis are outlined retrosynthetically in Scheme 22. The key 
steps involved an intramolecular aldol reaction, a samarium 
diiodide-mediated ring-expansion as previously adopted by Piers,37 and a 
one-pot iodination-elimination to introduce the C-11,12 olefin. 
Scheme 23 
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(a) i PhSH, t-BuOK, t-BuOH 35°C, 10h, 99%; ii Lithium naphthalenide THF, -78°C, 30 min, 
86%; (b) i ethylene glycol, CH(OEt)3 PTSA, CH2Cl2, rt, 4h, 91%; ii m-CPBA, CH2Cl2, -40°C, 
1h, quant; iii TFAA, TEA, rt, 3h, 87%.  
 
Nakada began with synthesis of the chiral building blocks 14662 and 14763. 
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PhSH mediated ring opening of cyclopropane 148 followed by reductive 
removal of the sulfone gave ketone 149 (Scheme 23). Straightforward 
functional group manipulation on 149 gave the desired 146 in two steps.  
Scheme 24 
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(a) baker’s yeast; (b) Me4NH(OAc)3; (c) i H2, Raney-Ni, rt, 12h, quant; ii 
p-MeOPhCH(OMe)2, CSA CH2Cl2, rt, 2h, 90% (d) i TBSOTf, DIPEA rt, 1h, quant; ii 
DIBAL-H, hexane rt, 4h, 97% (e) PPh3, I2 imidazole benzene reflux overnight, 93%. 
 
Chemoenzymatic reduction of the readily available 150 with baker’s yeast,63 
followed by Me4NH(OAc)3 reduction gave diol 152 (Scheme 24). The three 
oxygens in 152 were fully differentiated in four steps to provide 154 that was 
easily converted into the desired iodide 147. 
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(a) t-BuLi -78°C Et2O/THF (10:1); Fragment A -78°C to rt 79%; (b) i NHMDS, CS2, MeI, rt, 
10h, 91%; ii n-Bu3SnH, AIBN (cat), toluene reflux, 2h, 89%; (c) i 2NHCl/THF(1:2) 50°C, 11h, 
quant; ii Dess-Martin periodinane CH2Cl2, rt, 1h, 93%; (d) t-BuOK benzene 0°C to rt 2h, 
94% (e) SOCl2 Py CH2Cl2 0°C to rt 2h; (f) 2-bromopropene, t-BuLi, Et2O, -78oC 1h, 72%. 
 
After halogen-metal exchange, fragment 147 was coupled with fragment 
146 to furnish 155 as a mixture of diastereomers (Scheme 25). 
Deoxygenation of 155 was achieved by tinhydride reduction of the 
corresponding methyl xanthate to give 156. Removal of the silyl ether and 
ethylene acetal protecting groups in 156 followed by Dess-Martin oxidation 
provided the diketone 145. Intramolecular aldol reaction of 145 was 
achieved in an aprotic solvent to furnish 157. Dehydration of 157 gave a 
separable mixture of 158 and 159. Treatment of 159 with base isomerizes 
the C-4,5 double bond into the required position to provide 158.  
Reaction of 158 with isopropenyllithium gave 160 (Scheme 26). Subjecting 
160 to hydrogenation served to remove the MPM group with concomitant 
reduction of the isopropenyl double bond. Dess-Martin oxidation of the 
resulting alcohol 161 followed by dehydration gave a mixture of 
 31
regioisomeric alkenes. This mixture was isomerized to the desired 
conjugated diene 144 by refluxing in benzene in the presence of p-TsOH.  
 
Scheme 26 
O
OMPM
H
OMPM
H OH
OH
H OH
a b c
158 160 161
O
d
O
e
CO2Me
I O
CO2Me
144 162 163
f
O
CO2Me
g
HO
CHO
10 allocyathin B259  
 
(a) 2-bromopropene t-BuLi, Et2O -78°C, 1h 72%; (b) H2 (1atm) Pd/C MeOH rt, 6h, 96%; (c) 
i Dess-Martin periodinane CH2Cl2, rt overnight, 92%; ii SOCl2, Py CH2Cl2 0°C to rt 2h, 90%; 
iii PTSA, C6H6 reflux, 6h 85%; (d) i LHMDS, NCCO2Me THF, -78°C, 0.5h, 87%; ii CH2I2, 
TBAF, THF 0°C to rt, 0.5 h, 86%; (e) SmI2, HMPA THF, -78°C, 10 min, 91%; (f) i LDA (5 
eq), THF -78°C to 0°C, 1h; ii I2 (2 eq) THF, -78°C to 0°C, 1h, 71%; (g) i LiAlH4, Et2O, -78°C 
10 min, 89%; ii MnO2, CH2Cl2, rt 12h, 90%.  
 
Conversion of 144 to the corresponding β-keto ester64 was followed by 
iodomethylation to provide 162 as the key intermediate for ring expansion 
(Scheme 26). Samarium diiodide-mediated ring expansion of 162 furnished 
163 with the desired 5-6-7 tricyclic system. The C-11,12 double bond was 
introduced by a one-pot65-67 operation, which involved treatment of 163 with 
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excess LDA followed by I2 to give 59. Global reduction of the ketone and the 
ester in 59 followed by selective oxidation of the resultant allylic alcohol by 
the known protocol completed the total synthesis of (+)-allocyathin B2. 
 
1.4.6 Trost’s synthesis 
Scheme 27 
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The enantioselective synthesis of allocyathin B2 by Trost68 is based on a 
strategy that takes advantage of the palladium-catalyzed asymmetric allylic 
alkylation69,70 of prochiral ketone enolates (Scheme 27). The six-membered 
B ring was prepared through a transition metal-catalysed cycloisomerization. 
The assembly of the highly functionalized seven-membered ring was 
deferred to the last stage in the synthesis via an aldol cyclization. 
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(a) LDA, [(η3-C3H7)PdCl]2 (0.5 mol %), (S,S)-L* (1 mol %), allylacetate, Me3SnCl, t-BuOH, 
83%, 95% ee; (b) Me2CuLi, -20oC to room temperature, 86%; (c) LDA, PhNTf2, 96%; (d) 
Pd2(dba)3CHCl3 (2.5 mol %), PPh3 (20 mol %), CuI (5 mol %), TMS-acetylene, BuNH2, 
50oC, 85%; (e) OsO4 (1 mol %), NMO; NaIO4, 87%; (f) NaBH4, 94%; (g) PPh3, I2, ImH, 97%; 
(h) t-BuLi, ZnCl2, -78 oC to room temperature, then Pd(PPh3)4 (5 mol %), 12; (i) K2CO3, 
MeOH, 74% from 11; (j) n-BuLi, (Boc)2O, -78oC to room temperature, 99%; (k) TBAF, 
52-55%. 
 
The synthesis commenced with asymmetric allylic alkylation of 16771 
followed by addition of lithium dimethylcuprate (Scheme 28). Subjecting the 
resulting ketone 169 to triflation followed by a Sonogashira coupling72 
reaction generated the enyne 166. The further elaboration of the Z-alkene 
was accomplished by oxidative cleavage of the allyl side chain followed by 
reduction, iodination and a Negishi coupling73,74 reaction and 
monodesilylation to provide the alkyne 172. The straightforward acylation 
and deprotection of 172 provide the ynoate 173 which is ready for the 
pivotal cycloisomerization to construct the six-member B ring. 
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(a) 20 mol % CpRu(CH3CN)3PF6,100 mol % DMF, 2-butanone (0.1 M), rt, 55%; (b) 
PhS(O)CH2CN, piperidine, 75%; (c) 10% Pd/C, H2, 83%; (d) DIBAL-H; (e) KOH, MeOH, 60 
oC, 51% from 176. 
 
The key metal-catalyzed cycloisomerization of 1,6-enynes was investigated 
with both palladium and ruthenium75-78 catalysts (Scheme 29). Eventually, 
the Ru-catalyzed cycloisomerization of the 173 gave compound 165 in 48% 
yield as a single diastereomer. The aldehyde substituent of 165 was 
extended via a hydroxylative Knoevenagel reaction79-81 to generate the 
lactone 175. Selective hydrogenation of 175 followed by a DIBAL-reduction 
set the stage for the construction of the seven-membered C ring. The 
intromolecular aldol condensation of the aldehyde 173, similar to the Tori 
route,33 completed the synthesis of 10 in 19 steps from 2-methyl 
cyclopentanone. 
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1.4.7 Danishefsky’s synthesis 
Danishefsky’s82 asymmetric total synthesis of a member of this cyathane 
sub-family scabronine G is the first synthesis of this class of tricyclic 
diterpenoids. The general features of Danishefsky’s synthesis are outlined 
retrosynthetically in Scheme 30. The key steps involved Nazarov83 
cyclization of divinyl ketone 180 to assemble the A ring, stereoselective 
Nagata addition to introduce the isopropyl group and C-17, and the HgCl2 
mediated ring expansion of 178 to construct the seven-membered C ring.  
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The synthesis commenced with the dissolving metal reduction of enone 181 
and acylation of the resulting enolate with Mander’s reagent84 to provide the 
ketoester 182 (Scheme 31). Subsequent enol triflation and hydride 
reduction59 of 182 afforded the ester 183. Addition of vinylmagnesium 
bromide to the corresponding Weinreb amide85 of 183 generated the divinyl 
ketone 180. The desired cyclopentenone 179 was prepared as a single 
isomer via a Lewis acid-mediated Nazarov cyclization of 180. An axial 
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conjugate addition of a cyanide nucleophile86 to 179 was envisioned 
through stereoelectronic principles. Trapping the enolate87 resulting from 
cyanide addition to 179 as its triflate followed by Negishi coupling gave 185 
with the isopropyl group installed at the C-2 position. Reduction of the nitrile 
in 185 followed by oxidation, methylation and deketalization generated the 
cyclohexanone 178.  
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(a) Li/NH3, t-BuOH, THF, -78 oC; NCCO2Me, 72%; (b) NaH, PhNTf2, DME, 98%; (c) 
Pd(PPh)3, Bu3SnH, LiCl, THF, 55 oC, 91%; (d) LHMDS, Me(OMe)NH‚HCl, THF, -10 oC, 
79%; (e) vinylMgBr, THF, -10 oC, 84%; (f) FeCl3, CH2Cl2, 72%; (g) Et2AlCN, THF, Et3N, 
TMSCl; (h) t-BuOK, THF, -78 oC, N-(5-chloro-2-pyridyl)triflimide, 86% over two steps; (i) 
i-PrMgCl, ZnCl2, LiCl, (dppf)PdCl2, THF, 55 oC, 75%; (j) DIBALH, CH2Cl2, -78 oC, 88%; (k) 
NaClO2, NaH2PO4, t-BuOH/H2O; (l) MeI, K2CO3, DMF; (m) THF, HCl/H2O; 92% over three 
steps. 
 
Conversion of the cyclohexanone 178 to the thiopropylmethylidene 
intermediate 186 was achieved in two straightforward steps (Scheme 32). 
Subsequent addition of lithiated methoxymethylphenyl sulfide gave alcohol 
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187 and set the stage for the pivotal rearrangement step. The 
HgCl2-mediated ring expansion88 of 187 followed by isomerization of the 
double bond afforded scabronine G methyl ester 188, that was hydrolyzed 
to provide the natural product 33 after chemoselective protection of the 
aldehyde group. 
 
Scheme 32 
H
MeO2C
O a, b
H
MeO2C
O
SPr
H
MeO2C
OH
SPr
c
OMe
SPh
178 186 187
d
MeO2C
CHO
H
O e
MeO2C
CHO
H
O
HO2C
CHO
H
Of, g
177 188 33  
 
(a) NaH, HCO2Me, DME, 97%; (b) n-PrSH, TsOH, PhH, 50 oC, 93%; (c) 
n-BuLi/MeOCH2SPh, THF, -78 oC; (d) HgCl2, HCl/MeCN, 80 oC, 86% over two steps; (e) 
DBU, benzene, 75 oC, quant; (f) TsOH, HO(CH2)2OH, PhH, 89%; (g) aq. NaOH, MeOH, 55 
oC, then HCl, 87%. 
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1.4.8 Paquette’s approach 
Scheme 33 
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Dahnke and Paquette89 reported a synthetic approach to cyathanes which 
rapidly provided enantiopure ketone 190. The general features of 
Paquette’s approach are outlined retrosynthetically in Scheme 33. The key 
steps involved an inverse electron demand Diels-Alder reaction to introduce 
the seven-membered C-ring, a sigmatropic rearrangement to furnish the 
5-6-7 tricyclic system, and Johnson's sulfoxime resolution to arrive at 
enantiopure ketone 196. 
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(a) cat. Et3N, 120°C, 56%;  (b) DIBAL-H, MeCN, HMPA, THF, 92%; (c) HO(CH2)2OH, 
p-TsOH, 98%; (d) chloramine-T, acetone, aq. MeOH, 56%;  (e) Johnson's sulfoxime 
resolution, 87%;  (f) tBuLi, A, 51%; (g) KH, 18-crown-6, THF, 90°C, 83%. 
 
Paquette’s synthesis commenced with an inverse electron demand 
Diels-Alder reaction between tropone and dithioketene acetal 194 to 
provide 192 (Scheme 34). Selective reduction of the resulting enone 
followed by protecting group manipulation yielded ketone 196. Ketone 196 
was resolved via Johnson's sulfoxime method. The key intermediate 191 
was prepared by direct addition of the enantiopure organolithium reagent 
derived from (-)-197 to 196. Subjecting the resulting alcohol 191 to 
potassium hydride in the presence of 18-crown-6 generated the 
corresponding oxyanion, which triggered an oxy-Cope rearrangement to 
furnish 190 with the desired 5-6-7 tricyclic ring system. This transformation 
served to close the B-ring by forming the C4-C5 bond with concomitant 
fragmentation of the bicyclic system to unmask the C-ring by breaking the 
C8-C11 bond. 
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Scheme 35 
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(a) KH, MeI, THF, 87%;  (b) LHMDS, CIP(O)(OEt)2, THF, 87%;  (c) H2, PtO2, 90%; (d) Li, 
EtNH2, EtOH, Et2O, 95%;  (e) HCl, THF, 57%;  (f) KH, MeI, THF, 59%; (g) KHMDS, 
(TMSO)2, THF, 46%;  (h) MeMgBr, THF, 99%. 
 
With the tricyclic system 190 in-hand, the stage was set for the installation 
of the trans-methyl groups at C6 and C9. Direct methylation of enolate 190 
under thermodynamic control selectively yielded the desired isomer 198 
(Scheme 35). The face selectivity of this reaction is governed by the 
concave shape of 190. However, this also makes addtion of the C-6 methyl 
group from the opposite face difficult, and gave the wrong stereoisomer 202. 
An indirect method via pinacol rearrangement was also attempted but 
without success. 
 
1.4.9 Wright’s approach 
Wright90 reported a synthetic approach to cyathanes, that rapidly furnished 
the 5-6-7 tricyclic system. The general features of Wright’s approach are 
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outlined retrosynthetically in Scheme 36. The key steps involve an 
electrochemical mediated furan annulation91-93 and an intermolecular 
4C+3C cycloaddition94-97 on the annulated furan. Wright’s approach 
targeted the advanced intermediate 204, which could be a potential 
precursor to a variety of cyathins. Wright envisioned that compound 204 
could be derived from the oxo-bridged tricycle 205.  
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Wright’s approach began with cuprate addition to 3-methylcyclopentenone 
208 and trapping the enolate with TMSCl as silylenol ether 209 (Scheme 
37). The cuprate was generated from 20798 in situ via the Grignard reagent. 
Subjecting 209 to electrochemical oxidation closed the six-membered 
B-ring, providing the tricyclic furan 206 as a single isomer. Reaction of the 
derived acetal 211 with the oxyallyl cation generated from 
1,1,3-trichloroacetone and sodium trifluoroethoxide gave 211 with high face 
selectivity. Reductive dechlorination of 211 provided 205, the most 
advanced structure reported from this approach to date. Although 205 has 
the complete 5-6-7 ring system, further elaboration is still required; i.e. the 
methyl group at C-6, the isopropyl group at C-3, the trans 6-7 ring fusion, 
and extensive oxygenation needed to complete the cyathane skeleton. 
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(a) Mg, THF;  (b) CuI, TMSCl, Et3N, -78°C to r.t;  (c) anodic oxidation, MeCN, iPrOH, 
LiClO4, 2,6 lutidine, 65%;  (d) p-TsOH, HO(CH2)2OH, CH(OEt)3, 85%;  (e) 1,1,2 
trichloroacetone, NaOCH2CF3, CF3CH2OH; (f) Zn-Cu couple, NH4Cl, MeOH, 75% 2 steps. 
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1.4.10 Magnus’ approach 
Scheme 38 
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Magnus99 developed an elegant approach for rapidly providing the 5-6-7 
tricyclic system with 1,4-anti methyl groups as present in the cyathanes. 
The general features of Magnus’ approach are outlined retrosynthetically in 
Scheme 38. The key step involved oxidative rearrangement of a 
furylmethanol to provide the precursor for an intramolecular pyrylium 
ylide-alkene [5+2] cyclization100-105 to furnish both the B and C ring in one 
operation. Magnus’ synthesis commenced with a Dieckmann cyclization of 
diethyl adipate. Methylation of the resulting keto ester followed by 
decarboxylation yielded ketone 216 (Scheme 39). 
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Scheme 39 
O
O
O
O O
O
OTBS
O
OH
OH
O
O
HOO
O
O
OTBS
Li
a,b,c d,e
f,g
h,ij
215 216
217 218
214219212  
(a) KOEt, 2-iodopropane;  (b) NaOEt, MeI, Toluene;  (c) H2SO4, H2O, reflux;  (d) LDA, 
THF, 4-iodo-2-methyl-1-butene, 53%;  (e) CeCl3, A, 90%;  (f) SOCl2, pyridine, 94%;  (g) 
CsF, 97%;  (h) O2, hv, rose bengal;  (i) Me2S;  (j) TFA, DCM, 62% 3 steps. 
 
Regioselective alkylation of the enolate of 216 followed by addition of the 
2-lithiofuran derivative 217 gave 218 as a mixture of isomers. Dehydration 
of this mixture of alcohols followed by deprotection gave 214. Subjecting 
214 to William’s oxidative rearrangement106 protocol provided the desired 
precursor 219. Treatment of 219 with TFA generated the transient dipolar 
intermediate, which triggered the intramolecular [5+2] cycloaddition107 and 
arrived at 212. Further elaboration of the C-ring is still required to complete 
the synthesis of cyathane skeleton. 
1.4.11 Wender’s approach 
Wender108 reported an approach toward (+)-allocyathin B2 starting from 
commercially available (S)-(-) limonene. The general features of Wender’s 
approach are outlined retrosynthetically in Scheme 40. The key step 
involved an intramolecular [5 + 2] cycloaddition to assemble the B and 
C-rings in one operation. 
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Wender’s approach started with enantiopure 224 prepared from 
(S)-(-)-limonene by chemselective hydrogenation, Johnson-Lemieux 
oxidation, and intramolecular aldol (Scheme 41). DIBAL-H reduction of the 
enal 224 followed by vinyl ether formation and Claisen rearrangement gave 
aldehyde 222 as the major isomer. Aldehyde 222 was reduced and the 
resulting alcohol protected as a tert-butyldimethylsilyl ether followed by 
ozonolysis to afford the ketone 226. Reaction of 226 with the organocerium 
reagent prepared from cyclopropylacetylide followed by selective reduction 
of alkyne 223 provided 227 with the vinylcyclopropane installed. 
Deprotection of the primary alcohol in 227 and subsequent Dess-Martin 
oxidation, Grignard addition, and oxidation gave the key precursor 221.  
Subjecting 221 to Rh-catalyzed [5 + 2] cycloaddition protocol gave the 
cycloadduct 220 in good yield. Several key transformations remain to be 
established if 220 is to be used as a precursor for the synthesis of a 
cyathane diterpene. 
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(a) H2, PtO2, 94%;  (b) 1 mol % OsO4, NaIO4, THF/H2O, 97%;  (c) piperidine, AcOH, PhH, 
75%; (d) DIBAL-H, Et2O, 0 °C, 96%;  (e) EtOCH=CH2, Hg(OAc)2, then PhCH3, 90%;  (f) 
NaBH4, MeOH/H2O, 95%;  (g) TBSCl, imidazole, DMF, 90%;  (h) O3, CH2Cl2, -78 °C, 
Me2S, 65%; (i) 1-ethynylcyclopropane, n-BuLi, CeCl3, 0 °C, 91%;  (j) LiAlH4, MeONa, THF, 
69%; (k) DMP, NaHCO3, CH2Cl2;  (l) MeCCMgBr, THF, 75% over two steps;  (m) DMP, 
NaHCO3, CH2Cl2, 93%;  (n) 5 mol % [Rh(CO)2Cl]2, 1,2-dichloroethane (0.02 M), 80°C, 3.5 
h, 90%. 
 
1.4.12 Takeda’s approach 
Takeda109 developed an approach toward allocyathin B2, outlined 
retrosynthetically in Scheme 42. The key step involved a Brook 
rearrangement-mediated [3 + 4] annulation.110-113 Two retrosynthetic 
pathways have been addressed based on this transformation. 
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Path A commenced with ZnI2 catalyzed nitrile addition followed by POCl3 
mediated elimination to provide 237 (Scheme 43). Quenching the DIBAL-H 
reduction of 237 with an acid yielded aldehyde 238. Sequential 
dimethyl(phenyl)silyllithium addition114 and TPAP oxidation converted 238 
into the desired acylsilane. Treatment of 255 with the lithium enolate of 
4-methoxy-3-buten-2-one (231) gave the 1,2-adduct 239, which underwent 
a Brook rearrangement to 240 triggering the anionic oxy-Cope 
rearrangement to furnish 230. 
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(a) Me3SiCN, ZnI2;  (b) POCl3, Py, 65% 2 steps;  (c) DIBAL-H;  (d) (COOH)2, 76%, 2 
steps; (e) PhMe2SiLi, THF/HMPA, -80°C, 55%;  (f) n-Pr4NRuO4, NMO, MS-3A, DCM, 57% 
(g) THF, 0°C to rt. 
 
Path B started with Grignard addition of ethynylmagnesium bromide to 210 
followed by a Rupe rearrangement115 to give bicyclic methyl ketone 
(Scheme 44). Key [3 + 4] cyclization of 234 with acryloylsilane provided 233 
as a single diastereomer. Enone 246 was achieved after deprotection of 
245, which was derived from DIBAL reduction of 233. 
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Scheme 44 
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(a) THF, 0°C to rt, 92%;  (b) HCO2H, reflux, 42%;  (c) THF, -80°C to 0°C;  (d) DIBAL, 
Et2O, -80°C, 72%; (e) NBS, THF;  (f) n-Bu4NF, 72%, 2 steps;  (g) i-PrMe2SiCl, imidazole, 
92%. 
 
 
 
1.4.13 Didier-Desmaĕle’s approach  
Didier-Desmaĕle116,117 disclosed an approach to cyathanes starting from 
enantiomerically pure building block 256 (Scheme 45). The key step 
involved an intramolecular palladium-catalyzed cyclization. The original 
plan was to set up the cyathane ring system via a Heck-type118 cyclization 
of triflate 252. Due to the non-availability of required ester 254, an 
alternative plan was adopted, requiring a one-carbon ring expansion at a 
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later stage. 
Scheme 45 
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Chiral building block 256 was derived from 1-methylcyclopentanone via 
asymmetric Michael addition in the presence of (S)-1-phenylethylamine.119 
Treatment of 256 with sodium borohydride yield a mixture of epimeric 
alcohols, which were protected as TBDMS ethers (Scheme 46). After 
saponification, the corresponding acid was converted to iodide 255 through 
a Barton-modified Kochi reaction. DMPU mediated coupling between 253 
and the lithium enolate of 255 furnished the desired diene 259. After 
removal of the TBDMS group, the resulting alcohol was converted to the 
triflate 251 through a sequential Swern oxidation and triflation. Treatment of 
triflate 251 with Pd2dba3 in the presence of tetrabutylammonium acetate in 
DMSO furnished the tricyclic acetate 250. 
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Scheme 46 
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(a) NaBH4, MeOH, 0°C, 91%; (b) TBDMSCl, Im, DMF, 20°C, 12 h, 90%; (c) aq. KOH, 
MeOH, 20°C, 89%; (d) Pb(OAc)4 / I2 , 6 h, refluxing CCl4 ; (e) i., LDA, THF, -78°C, 1 h, ii. 
DMPU, THF, 50°C, 3 h, 83%; (f) n-Bu4NF, THF, 60°C, 5 h, 78%; (g) (ClCO)2 , DMSO, 
CH2Cl2 , -78°C, then Et3N, 95%; (h) 2,6-di-tert-buylpyridine, Tf2O, CH2Cl2 ,0°C, 79%; (i) 
Pd2(dba)3, n-Bu4NOAc, LiCl, DMSO, 60°C. 
 
With 250 in hand, the stage was then set for a one-carbon expansion of the 
C-ring. Installation of the C-14 hydroxyl group before the ring expansion 
turned out to be difficult. Saponification of the acetate in 250 followed by 
allylic oxidation yielded ketone 261 (Scheme 47). Sequential Birch 
reduction and oxidation of 261 provided the desired ketone 262. Treatment 
of 262 with (trimethylsilyl)diazomethane in the presence of Me3Al gave a 
1.5:1 mixture of ketones 248 and 249. Further elaboration of these ketones 
has not been reported. 
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Scheme 47 
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(a) MeONa, MeOH, 20°C, 3h, 96%; (b) MnO2, toluene, 80°C, 3h, 73%; (c) Li, NH3, 
t-BuOH-THF, -78°C; (d) PCC, CH2Cl2, AcONa, 4A sieves, 20°C, (g) i. TMSCHN2, AlMe3, 
-78 to -20°C, 3 h, ii. TFA, THF, H2O, 78%. 
 
 
1.5 Conclusion 
In spite of the versatile approaches that have been developed, only three of 
them can provide the trans-fused 6,7 ring system: Piers’ synthesis of 
sarcodonin G (26); Danishefsky’s synthesis of scabronine G (33) and 
Ward’s synthesis of allocyathin B3 (3). Because the trans-fused 6,7 ring 
system is one of the key structural features of the cyathin family (present in 
ten out of eleven cyathins), these three approaches potentially can be 
modified to synthesize other cyathins. Among these approaches, 
Danishefsky’s approach is the only one that provides enantiomerically pure 
product by using (-)-Wieland-Miescher ketone as the starting material. 
Therefore, incorporating an enantioselective reaction into Ward’s approach 
would result in a most attractive general approach toward asymmetric 
synthesis of cyathin diterpenes.  
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2. Results and Discussion 
2.1 Objectives of thesis research 
The Ward group’s 1st generation synthetic approach to cyathanes 
culminating in (±)-allocyathin B3 was described in section 1.4.4 (see page 
20). Because the synthetic route established a trans B-C ring fusion, a fully 
functionalized C ring, and proceeded via intermediates having useful 
functionalities in the A ring and the isopropyl group, it had the potential to 
provide access to any of the known cyathin diterpenes. The goal of my 
thesis research was to establish an enantioselective 2nd generation 
synthetic route to cyathane diterpenes. The specific objectives for the 2nd 
generation synthesis were: 
 
Objective 1: Develop an enantioselective version of the first Diels-Alder reaction.   
O
O
OTMS
TMSO
O
O
OTMS
OTMS
H
+
chiral catalyst
106 105 108  
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Objective 2: Establish a more direct route from 110 to 115. 
O
O
O
H
OH
O
H
H
OHhydration stereoselective
reduction
aldol
isomerization
110 115  
 
Objective 3: Develop a more direct approach to introduce the isopropyl group. 
OMe
O
H
OBzO
OMe
O
H
OBzO
103 102  
 
Objective 4: Establish a synthetic route to cyathin A3 
OMe
OO
H
O
OHH
OH
O
102 cyathin A3  
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2.2 Enantioselective quinone Diels-Alder reactions 
2.2.1 Introduction   
Diels-Alder reactions with a quinone as the dienophile are a powerful 
method to construct functionalized cis-fused decalin systems, and have 
been applied to many syntheses of complex natural products.120 However, 
general methodology for conducting the key quinone Diels-Alder reaction 
enantioselectively is not yet available. In most examples, the initial 
Diels-Alder reaction generated a racemic adduct from which the synthesis 
of an enantiomerically pure natural product can only be achieved with a 
resolution step. 
O
O
O
O
O
O
O
O O
OO
O
O
O
H
H
O
O
H
H
A BA B
A B A B
Enantioselectivity site selectivity
face selectivityregioselectivity
  
Figure 8. Control elements in enantioselective quinone Diels-Alder reaction 
 
The enantioselective quinone Diels-Alder reaction is challenging because 
of the multiple requirements of high face-selectivity, regio-selectivity (i.e., 
only one of the two possible modes of coupling an unsymmetrical diene and 
 56
a unsymmetrical dienophile), and site-selectivity (i.e., reaction at only one of 
the C=C subunits of an unsymmetrical quinone). Several approaches to this 
problem have been reported. 
 
2.2.2 Use of a chiral diene 
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Between 1983 and 1989, Stoodley121-123 et al. reported the preparation of 
several chiral alkoxy dienes based on a peracetylated glucopyranosyl 
auxiliary. Although good diastereoselectivity was observed with the highly 
reactive benzoquinone, the authors did not extend the scope of the method 
to any other quinone, which has proven to be less reactive. 
 
2.2.3 Chiral Lewis acid catalyzed reactions 
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Figure 9. Lewis acid coordination with α, β-unsaturated carbonyls 
 
The success of chiral Lewis acid-mediated Diels-Alder reactions relies on 
the selectivity of the coordination of the carbonyl with the Lewis acid (for 
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dienophiles containing α, β–unsaturated carbonyls) and a highly organized 
transition state. Selective coordination usually depends on steric control 
(aldehydes), stereoelectronic control (esters, amides), or chelation control. 
Lewis acid coordination is usually a nonselective process with unsaturated 
ketone dienophiles because the participating lone pairs are positioned in 
similar steric and electronic environments (Figure 9).  
2.2.3.1 Evan’s catalyst 
In most cases, formation of a highly organized transition state relies on 
two-point ligation of a chiral catalyst to the dienophile, often a dicarbonyl 
system124, so that only one face of the dienophile is exposed to the diene 
partner. Single-point ligation often leads to poor levels of enantiocontrol and, 
ultimately, has limited the use of simple ketone dienophiles, such as 
quinones, in catalytic asymmetric Diels-Alder reactions. Single-point ligation 
of an achiral dienophile to an asymmetric catalyst generally requires a 
secondary interaction, either electronic or steric, between the dienophile 
and catalyst for good enantioselectivity.  
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One recent example reported by Evans et al. involves a DA reaction of 
substituted benzoquinone 266 catalyzed by chiral rare earth Lewis acid 269. 
The ester group present in the benzoquinone 266 activates the attached 
double bond and provides an extra binding site that directs Lewis acid 
coordination to the adjacent carbonyl group of the quinone. The diene 
selectively adds to the more hindered double bond with high regio and 
enantioselectivity indicating the transition state is well controlled by the 
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multiligation strategy.  
2.2.3.2 Corey’s catalyst 
N
B
O
H
H
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O
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The chiral cationic oxazaborolidinium ion 273 developed by Corey et al. is a 
useful and potent catalyst for promoting a wide variety of highly 
enantioselective Diels-Alder reactions.125 The catalyst has been applied to 
a number of enantioselective reactions of unsymmetrical 1,3-dienes with 
quinones.126  These results provide guidance for the general use of the 
catalyst in quinone Diels-Alder reactions, which are summarized below.  
 
O
H R
O
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O
OMe
catalyst
O
O
R
O
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 Figure 10. Lewis acid coordinate to quinone carbonyl group. 
 
(1) For a quinone carbonyl flanked by a C-H and a C-R, the major product 
will result from catalyst coordination preferentially at the oxygen lone pair on 
the C-H side (a) rather than the C-R side (b) because (a) is sterically more 
accessible than (b); (2) Catalyst coordination at the more basic of the two 
1,4-quinone oxygens will predominate and will lead to the preferred 
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Diels-Alder adduct; (3) A quinone C=C bond with two hydrogens is more 
reactive than one bearing a substitutent, especially a σ-electron donating 
group; (4) For monosubstituted 1,4-quinones (or p-benzoquinone itself), the 
major product pathway will involve coordination of the catalyst at the C=O 
syn to the HC=CH subunit that undergoes [4 + 2]-cycloaddition; (5) C(1) of 
2-triisopropylsilyloxy-1,3-butadiene (270), the more nucleophilic end of the 
diene, will bond to the carbon distal from the carbonyl group that 
coordinates to the catalyst, i.e., the more electrophilic carbon.  
The use of 2,5-dimethyl-1,4-benzoquinone as a dienophile was of special 
interest because the expected coordination of the catalyst to the carbonyl 
lone pair anti to methyl would activate both C=C subunits of the quinone, 
leading to both possible adducts, as shown in Scheme 48.  
 
Scheme 48 
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Corey’s solution to this problem involved the utilization of 
3-iodo-2,5-dimethyl-1,4-benzoquinone as a synthetic equivalent of 
2,5-dimethyl-1,4-benzoquinone. The iodide substituent in the quinone 
deactivates the C=C subunit to which it is attached (C=C protection) and 
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also blocks catalyst coordination to the carbonyl lone pair which is syn to 
the iodine. In consequence, there is only one carbonyl lone pair in 3-iodo- 
2,5-dimethyl-1,4-benzoquinone that is sterically accessible for coordination 
with catalyst. 
 
O
O
I
[ less reactive][ more reactive]
H
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277  
Figure 11. Control element in 3-iodo-2,5-dimethyl-1,4-benzoquinone 
 
2.2.3.3 Mikami’s catalyst 
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Mikami127 et al. developed a chiral titanium catalyst that successfully 
catalyzed an enantioselective Diels Alder reaction of 281 with 
naphthoquinone 280. The catalyst used was derived from the reaction of 
(R)-BINOL with Cl2Ti(Oi-Pr)2 in the presence of 4 Å molecular sieves and 
H2O (referred to herein as the Mikami catalyst).45,128 Wright successfully 
used this catalyst in a total synthesis of ibogamine, which was the first 
asymmetric total synthesis relying on an enantioselective quinone Diels 
Alder reaction (Scheme 49).129  
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Scheme 49 
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It has been suggested that quinone ketals might be more useful quinone 
surrogates in these reactions (Scheme 50).130 There are a number of 
potential advantages of 1,4-quinone monoketals over the corresponding 
quinones, including: (1) monoketals are expected to be more Lewis basic; 
(2) they would provide adducts that do not undergo facile aromatization; (3) 
monoketals provide adducts in which one of the two carbonyls of the 
1,4-quinone is already protected, simplifying the task of further selective 
transformations.  
 
Scheme 50 
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The Mikami catalyst has been applied to enantioselective carbonyl addition, 
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ene reaction, aldol reaction, Michael reaction, [2+2] and [2+3] 
cycloadditions and Diels-Alder reactions. Despite the importance of these 
titanium BINOL complexes in asymmetric syntheses, there is very little 
information regarding the actual structure of this catalyst. A recent study on 
(BINOLate)Ti(OiPr)2 catalyst suggests three different BINOLate titanium 
complexes, and all of them are potential catalysts or pre-catalysts (Figure 
12). This study suggests that the actual structure of the Mikami catalyst 
might be difficult to determine due to the aggregation of titanium species. 
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Figure 12. Some proposed structures for titanium/BINOL catalyst based on 
X-ray analysis 
 
In the early study, the structure of the active titanium catalyst was assumed 
to be the BINOL-derived titanium dichloride 289.45  
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 Figure 13. Two proposed structures for Mikami’s catalyst 
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However, the dichlorotitanium complex 289 prepared from TiCl4 and BINOL 
dilithium salt does not show the same reactivity as Mikami catalyst 
(Scheme 51). In the glyoxylate–ene reaction, the dichlorotitanium complex 
289 gives the ene product 293 in low yield along with a low % ee. By 
contrast, use of 289 treated with commercially available MS-4A significantly 
increases the chemical yield and gives a higher % ee. This experiment 
suggests that the MS-4A converts the pre-catalyst 289 into the active 
BINOL-Ti catalyst. 
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Ph H CO2Bu
O
+
Catalyst
Ph CO2Bu
OH
Mikami catalyst 97% ee, 96% yield
289 53% ee, 31% yield
289 + MS-4A 89% ee, 74% yield
Ti
Cl
Cl+
OLi
OLi
iPrO
iPrO
291 292 293
294
O
O
Ti
Cl
Cl
289  
An analytical sample of the Mikami catalyst was prepared from BINOL and 
[TiCl2(OiPr)2] in the presence of MS 4A doped with H217O. The 17O NMR 
spectrum of the active BINOL–Ti catalyst in toluene-d8 reveals peaks only 
in the μ3-oxo (Ti3O) region (δ 520–590). Furthermore, elemental analysis of 
the active catalyst revealed only a low amount of Cl (Found: Ti, 11.4; Cl, 
0.6%; Cl/Ti = 0.07. Calc. for 289: Ti, 11.9; Cl; 17.6%). These results 
suggest that the active species of the chiral titanium catalyst is not the 
dichlorotitanium complex 289 but a μ3-oxo (Ti3O) 290 (Figure 13). 
Mikami observed a remarkable non-linear effect with this catalyst. For 
example, in a standard glyoxylate-ene reaction, the use of a catalyst 
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prepared from BINOL of 33% ee provided the ene product with 91% ee in 
92% chemical yield. The ee thus obtained is not only much higher than that 
of the BINOL employed, but also very close to the value (94.6% ee) 
obtained by use of enantiomerically pure BINOL. This result implies that the 
active catalyst is a dimer (or oligomer) and that homochiral aggregates are 
more reactive than heterochiral aggregates. 
2.2.4 Development of an enantioselective Diels-Alder 
reaction of 105 with 106 
2.2.4.1 Preliminary attempts 
Initial attempts to effect an enantioselective Diels-Alder reaction of 
2,5-dimethylbenzoquinone (106) with diene (105) using the Mikami catalyst 
failed (Scheme 52). The reaction according to White’s general protocol131 
gave cycloadducts in no more than 5% yield. This result was attributed to 
the low reactivity of 106 and the instability of 105.  
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It should be noted that the reaction of benzoquinone with diene 105 was 
complete within a minute at room temperature while the reaction with 2,5 
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dimethylbenzoquinone required 48 h at 140oC to reach completion. In 
addition, diene 105 is readily hydrolysed and much less stable than the 
simple diene 283 used by White (Scheme 49). Increasing the amount of 
catalyst simply destroys the diene 105. 
   
2.2.4.2 Other Lewis acid catalysts 
Enantioselective Diels-Alder reactions of 105 with 106 catalyzed by Lewis 
acids other than Mikami’s catalyst were also investigated (Scheme 52, 
Table 1). Initially, achiral Lewis acids were tested for catalytic activity and 
diene stability. Among the various Lewis acids tested [Ti(OiPr)4, TiCl2(OiPr)2, 
(Chx)2BCl, B(OiPr)3, ZnCl2, Me3Al, MgBr2], only magnesium bromide was 
efficacious. Although substantial diene decomposition occurred in the 
presence of MgBr2, the addition of Et3N gave a 50% yield of the desired 
aduct 108. 
Table 1: Yield and ee of 108 obtained from Diels-Alder Reaction of 105 and 
106 using chiral Lewis acids 
Run Catalyst Yield % ee % 
1 MeMgBr / 298 47 15 
2 MeMgBr / 299 17 < 5 
3 MgBr2 / 300 50 < 5 
4 301 (X=Cl) 40 33 
5 301 (X=SbF6) 20 66 
6 AlMe3 / BINOL (288) 90 50 
7 302 0 --- 
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Based on the above results, three well known chiral magnesium bromide 
catalysts were tried; however, the enantioselectivities of these reactions 
were moderate (Table 1). Some additional chiral Lewis acids were also 
screened. Diene 106 decomposed in the presence of Corey’s catalyst (302) 
under the reported conditions. Jacobsen’s chromium salen catalyst (301) 
has been successfully applied in hetero-Diels-Alder reaction with Rawal’s 
amino-diene, which is also an acid sensitive diene.132-137 However, the 
chloride version of this catalyst gave poor enantioselectivity in the reaction 
of 105 with 106.  The selectivity was improved using the catalyst with a 
less coordinating SbF6
- counter ion. Aluminum BINOLate catalysts have 
been successfully employed in a variety of Diels-Alder reactions.138,139 
Although the catalyst prepared from 1:1 mixture of Me3Al and BINOL 
effectively promoted Diels-Alder reaction of 105 with 106, the 
enantioselectivety was modest.  
2.2.4.3 Organocatalysis 
The enantioselective catalysis of organic reactions using small organic 
molecules as catalysts is a rapidly growing research area. In principle, the 
proton can be considered the smallest hard Lewis acid to activate the 
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carbonyl group of a dienophile and catalyze the Diels-Alder reaction. Very 
recently, Rawal has reported that some chiral alcohols are able to catalyze 
the Diels-Alder reaction of aldehydes with the amino-diene 303 (Scheme 
53).140 However, applying this approach to the reaction of 105 and 106 was 
not very successful (Scheme 52). No product was observed from the 
reactions catalyzed by TADDOL catalysts 304 or 305. The reaction 
mediated by BINOL gave a 50% yield of the desired adduct 108 after 4 
days at room temperature; however the ee was only 5%.  
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2.2.4.4 Stabilizing the diene 105 
The previous results suggested that the stability of diene 105 was 
problematic in attempted Lewis acid mediated Diels-Alder reactions with 
106. Optimization was therefore focused on modifying the reaction 
conditions to improve the stability of diene 105. The first assumption was 
that the HCl generated during the titanium catalyst formation was 
detrimental to the diene. Control experiments indicated that 105 was more 
stable to TiCl2(OiPr)2 in the presence of a hindered amine base (e.g. 
1,2,2,6,6-pentamethyl  piperidine). However, no Diels-Alder adducts with 
106 could be obtained under these conditions, presumably because the 
added base deactivated the Ti(IV) Lewis acid. The methoxy dienes 308-309 
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were prepared in hope that they would be more stable to hydrolysis than 
105 (Scheme 53). However, these dienes were also hydrolyzed by 
Mikami’s catalyst and the Diels-Alder adducts with 106 were not obtained. 
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Similar chiral dienes 312 were also prepared. These dienes were very 
unreactive. For example, reaction with 106 did not give Diels-Alder adducts 
after 48h at 140oC.  
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2.2.4.5 Systematic Investigation with the Mikami Catalyst 
Scheme 55 
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In 2003, Corey reported a catalytic enantioselective Diels-Alder reactions of 
1,4-quinone monoketals using Mikami’s catalyst.130 In that paper, a different 
protocol to prepare the titanium BINOLate complex was described. 
Although using this catalyst failed to give the Diels-Alder adduct from 313 
and 105, a similar reaction of 105 with 106 gave 108 in 33% ee and 30% 
yield (Scheme 55). This result indicates that the procedure of making the 
catalyst is crucial. Therefore, the following conditions were systematically 
investigated: 
z amount of MS-4A; 
z moisture content of MS-4A; 
z amount of the catalyst; 
z ratio of TiCl2(OiPr)2 and BINOL; 
z additives 
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The Effect of Molecular Sieves (MS-4A) 
 
The structure of the Mikami catalyst is unknown, but it appears to involve 
μ-oxo bridges between at least two titanium centers. To convert the 
pre-catalyst into this active form, the MS-4A not only serves as the H2O 
donor to hydrolyze the titanium chloride pre-catalyst but also as a base to 
trap HCl. This mechanism suggests that the amount of the molecular sieves 
and the moisture content of the molecular sieves will affect the catalyst 
structure and reactivity.  
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As illustrated in Table 2, DA reactions of 105 with 106 catalyzed by 
Mikami’s catalyst were indeed affected by the amount of MS-4A. The yield 
of the reaction increased when more MS-4A was used (c.f. entries 2-3). 
However, the reaction failed with larger amounts of MS-4A (entry 4). The 
best range seems to be 50~100 mg per 10 μmol of the titanium complex. 
One hypothesis is that MS-4A removes any acidic species, which are 
detrimental to the diene, thereby improving the yield of the reaction. At the 
same time, the titanium-BINOL catalyst is also absorbed by the MS-4A, the 
large excess of MS-4A results in insufficient catalyst to promote the 
reaction.  
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Table 2: The effect of the amount of MS-4A used in preparation of the Ti(IV) 
BINOL catalyst on the DA reaction of 105 and 106  
O
O
+
OTMS
TMSO
O
O
OTMS
OTMS
H
106 105 108
Ti(IV) BINOL
MS-4A
25 ~ 200 mg
 
 
a. Contains 15% H2O by mass; b. μmol of Ti, catalyst prepared by Corey’s protocol;130 c. 
Based on NMR of the crude reaction mixture; d. Measured by NMR with TFAA as the chiral 
shift reagent. 
 
The H2O contained in the sieves is important in giving the active BINOL–Ti 
catalyst.128,141,142 MS-4A can be dried by heating at 180°C under vacuum. 
From gravimetric analysis, the H2O content in the commercially available 
activated MS-4A employed in the catalyst preparation was found to be 5% 
w/w. By contrast, the H2O content of old MS-4A (20 year) was found to be 
20% w/w. It’s worth noting that the “wet” MS-4A is much better than the 
“dry” one. The catalyst prepared from dry MS-4A can hardly promote the 
asymmetric Diels-Alder reaction of 105 and 106 (c.f. Table 3 entry 1).  
 
 
 
run MS-4Aa Time Yieldb ee%c 
1 25  mg/μmol d 2 d 18 67 
2 50  mg/μmol 2 d 21 67 
3 100  mg/μmol 6 d 52 43 
4 200  mg/μmol 6 d 0 --- 
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Table 3: The effect of moisture on the preparation of the Ti(IV) BINOL 
catalyst for Diels-Alder reaction of 105 and 106 
 
O
O
+
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O
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OTMS
H
106 105 108
Ti(IV) BINOL
MS-4A
dry ~ 20% H2O
 
 
run H2O%w/w a Method Yieldb ee%c 
1 Dry 180°C /0.01mmHg 12 20 
2 5% dry/20% 3:1d 18 33 
3 5% dry+DCM/H2Oe 23 67 
4 10% dry+DCM/H2O 33 78 
5 15% 130°C 7df 21 67 
6 20% 180°C 2h 25 82 
 
a. H2O in MS-4A w/w; b. Based on NMR of crude reaction mixture; c. Measured by NMR 
with TFAA as chiral shift reagent; d. Dry MS-4A mixed with “old” MS-4A (20% H2O) 3:1 
ratio; e. Water introduced to dry MS-4A by adding wet DCM (a known amount of water 
added to distilled dry DCM); f. “old” MS-4A (20% H2O) kept in an oven at 130°C for a 
week  
 
In contrast, the Mikami catalyst prepared in the presence of commercially 
available and unactivated MS-4A gave the product in higher chemical yield 
and much higher enantioselectivity (c.f. entry; 2-6). These results support 
the mechanism that MS-4A serves as an H2O donor to hydrolyze the 
titanium pre-catalyst.  
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Table 4: The effect of the catalyst a loading on the Diels-Alder reaction of 
105 and 106. 
O
O
+
OTMS
TMSO
O
O
OTMS
OTMS
H
106 105 108
Ti(IV) BINOL
5% ~ 22%
MS-4A
 
 
run mol% of catalyst %Conversion bYield% ee% 
1 5 33 21 67 
2 14 54 42 87 
3 22 23 18 89 
 
a. Catalyst prepared with 50mg MS-4A (15% H2O) per 10μmol Ti(IV); reaction in DCM at 
room temperature for 72h; b. measured by NMR of the crude reaction mixture. 
 
The catalyst loading of the DA reaction of 105 and 106 is limited by the 
stability of the acid labile diene 105.  Control experiments using impure 
(partially hydrolyzed) diene failed to produce DA adduct (<1%). This is 
attributed to a higher affinity of the hydrolized diene (i.e. 307) for titanium 
catalyst than 106. The data in Table 4 suggested that the maximum catalyst 
loading in the reaction was ca. 14 mol%. 
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Another approach to control the acidity of the catalyst is to change the 
titanium (IV) precursor. Mikami and Terada,128 and later Nakai et al., 
reported that reaction of (R)-BINOL with Ti(OiPr)4 and water, followed by 
heating and the azeotropic removal of isopropyl alcohol in refluxing toluene 
led to the formation of the same μ-oxo titanium complex 290. The side 
product HCl can be avoided in this process. The stability of diene 105 in the 
reaction catalyzed by this catalyst (prepared from Ti(OiPr)4) was much 
improved. However, the reaction was much slower compared to the one 
using catalyst prepared from TiCl2(OiPr)2 (20% yield, 25%ee, 2 day). This 
result suggests that 290 might not be the structure of the active titanium 
species.  
Table 5: The effect of the Ti : BINOL ratio on the catalyst performance 
O
O
+
OTMS
TMSO
O
O
OTMS
OTMS
H
106 105 108
Ti(IV) : BINOL
1:0.5 ~ 1:2
MS-4A
 
run Ti : BINOL Yield% ee% 
1 1:0.5 66 33 
2 1:1 65 82 
3 1:1.5 50 78 
4 1:2 57 58 
 
The proper ratio of titanium and BINOL is another key parameter for 
catalyst preparation. It was reported that catalysts prepared with BINOL to 
titanium ratios of 1:6, and 2:1 were optimal for asymmetric alkylation and 
asymmetric hetro-Diels-Alder reaction, respectively.30 The results in Table 5 
suggested that the catalyst prepared from a 1:1 ratio of BINOL to Ti (IV) 
was the optimal for the desired Diels-Alder reactions.  
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Very recently, Maruoka143 reported a new titanium catalyst 314 which can 
catalyze the asymmetric allylation of aldehydes. This catalyst can be 
generated by two different routes with Ag2O as the additive. The proposed 
structure is a different form of μ-oxo titanium. Surprisingly, the Diels-Alder 
reaction of 105 and 106 catalyzed by 314 gave 108 in 87% yield and 71% 
ee after 2 days. Although the ee of 108 was lower than had been obtained 
with other catalyst preparations, the much improved conversion suggested 
that a better catalyst might be prepared with the right additive.  
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Table 6: The effect of additives on the Diels-Alder reaction of 105 with 106 
using Mikami’s catalyst. 
O
O
+
OTMS
TMSO
O
O
OTMS
OTMS
H
106 105 108
Ti(IV) / BINOL
MS-4A
Additive
(Mg, SiO2)
 
run Additive (amount) Yield% ee% 
1 ---- 21 67 
2 Mg (5mg) 65 82 
3 Mg (10mg) 69 79 
4 Mg (20mg) 82 41 
5 Silica (5mg) 72 75 
6 Silica (5mg) Mg (5mg) 93 90 
 
a. Reaction in DCM at room temperature for 48h using 5 mol% catalyst (relative to Ti). 
Catalyst prepared using Corey’s protocol with MS-4A containing 5% water. 
 
The effects of magnesium powder and silica powder as additives were 
considered for study (Table 6). Both are readily available and easily 
separated from the reaction mixture. The rationale for adding magnesium 
powder was to neutralize any trace amount of HCl and other acidic species 
and thereby stabilize the diene. Both the yield and enantioselectivity of the 
reaction increased dramatically with the proper amount of magnesium 
powder (c.f. Table 6 entries 1-4). It’s important to note that the mass 
recovery of the intact diene also increased under these conditions, which 
provided a clue for further optimization. 
The utilization of silica as an additive was based on the concept of “surface 
organometallic catalysts”.144 The surface organometallic catalyst consists of 
a transition-metal-containing active site that is grafted onto a solid support 
that serves as a rigid ligand for the metal center. It has been shown that the 
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immobilized form of the catalyst (i.e., 318) was more than 20 times more 
active and far more selective than the solution-phase catalyst in olefin 
epoxidation reactions using organic hydroperoxides as oxidizing agents 
(Shceme 59).145 
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In the event, interesting and useful effects were observed including rate and 
selectivity enhancements, when silica was added to the titanium BINOLate 
catalyst (Table 6; c.f. entries 1, 2, 5, and 6). Optimal results were achieved 
with a combination of silica gel and magnesium powder (Table 6, entry 6). 
2.2.4.7 Final optimization and scaling up of the D-A reaction 
For practical synthesis, solvent-free conditions are ideal in terms of 
volumetric productivity and environmental safety. However, asymmetric 
catalytic processes are usually highly sensitive to solvents and the 
concentration of substrates. After careful optimization, much higher 
enantioselectivity (up to 95%) in the DA reaction of 105 with 106 was 
achieved under solvent-free conditions (Table 7). The optimized procedure 
involved adding 106 to a DCM solution of the Mikami catalyst prepared 
according to Corey’s protocol using MS-4A containing 5-6% water (w/w). 
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After 1h, the diene 105, Mg powder, and silica were added and the reaction 
mixture was concentrated to remove the DCM.   
Table 7: The effect of concentration on the enantioselective (5% Mikami 
catalyst) Diels-Alder reaction of 105 and 106. 
O
O
+
OTMS
TMSO
O
O
OTMS
OTMS
H
106 105 108
Ti(IV) / BINOL
MS-4A
Additive
(Mg, SiO2)
 
Run Concentration Yield % ee % 
1 0.28 M 93% 90% 
2 neat 85 ~ 90% > 95% 
 
The workup and purification of a Diels-Alder reaction with a 
Danishefsky-type siloxydiene is challenging because of the instability of the 
adducts. Typically, the adducts are fully or partially hydrolyzed during 
workup or on silica gel using standard procedures. Distillation was very 
effective for purification of racemic 108 from thermal DA reaction of 105 
with 106. However, even trace amounts of titanium species in the crude 
product from the enantioselective DA reaction were detrimental and caused 
decomposition during attempted distillation. After numerous experiments, a 
workup protocol for large scale enantioselective DA reaction was developed 
that involved a non-aqueous workup followed by removal of the excess 
diene by fractional distillation under high vaccum. The quality of the product 
obtained from this was similar to that obtained by distillation in the thermal 
reaction and it could be used for the subsequent photo reaction directly. 
2.2.4.8 Determination of the absolute configuration of 108 
In recent years there has been a marked increase in the number of papers 
describing the use of NMR for the assignment of the absolute 
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stereochemistry of organic compounds.146 The general procedure consists 
of the derivatization of the substrate of unknown configuration with each of 
the two enantiomers of an auxiliary reagent. The proton NMR spectra of the 
resulting diastereoisomeric derivatives are compared and the differences in 
chemical shifts measured to give a ΔδSR values. This method has been 
applied to secondary alcohols by preparing Mosher’s ester (MTPA) 
derivatives.147 The procedure for the assignment of the absolute 
configuration of a secondary alcohol bearing substituents L1 and L2 [i.e. 
L1L2CH(OH)], directly bonded to the stereogenic center, consists of a series 
of steps. These steps are as follows: 
1. Esterification of the substrate with the R and the S enantiomers of 
Mosher’s acid (MTPA). Assignment of the proton NMR signals from the L1 
and L2 parts of both derivatives.  
2. Comparison of the chemical shifts of the signals due to protons in L1 and 
L2 in both the R and the S derivatives and calculation of the corresponding 
differences expressed as ΔδSR. For each assignable proton, the ΔδRS is 
defined as the chemical shift of the signal for that proton in the derivative 
prepared from the (R)-MTPA minus the chemical shift of the related proton 
in the derivative prepared from the (S)-MTPA (ΔδSRL1 = ΔδSL1- ΔδRL1). The 
signs of the calculated ΔδSR ( + or - ) should be the same for all of the 
protons from the L1 substituent and opposite to those from the L2 
substituent. 
3. Consider the model in Figure 14 and insert the substituent with a positive 
Δδ and that with a negative Δδ in the appropriate place. Assign the absolute 
configuration of the substrate accordingly (Figure 14). 
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(R)-and (S)-Mosher's ester Substrate  
Figure 14. Model for assigning absolute configuration of 323 by NMR, from 
the signs of the calculated differences in chemical shift 
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Hydrolysis of 108 with TFA gave the known46,50 compound 297 (Scheme 
59). Reduction of 297 with DIBAL-H selectively gave the alcohol 320. 
However, attempts to prepare 321 from 320 were not successful. 
Alternatively, 297 was converted into 322 by treatment with ethanedithiol. 
Selective reduction51  of 322 with NaBH4 gave a separable 10:1 mixture of 
323 and 324 respectively. The relative configuration of 323 was assigned 
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based on NOE experiments (Figure 14). Positive NOEs were observed at 
HC-8’a and H3CC-4’a on irradiation of HC-8’ and at HC-8’a, HC-8’ and 
H3CC-4 on irradiation of H3CC-4’a. Esterification of 323 with (R)-MTPA and 
with (S)-MTPA gave 325 and 326, respectively. The 1H chemical shifts 
observed in the NMR spectra of 325 and 326 are shown in Table 7. 
 
O
HO
S
S
H
H
8'a
8'7'
6' 5' 4'a
1'
 
Figure 15. NOE correlations observed in 323. 
 
Table 8: 1HNMR chemical shifts (in Hz at 500 MHz) for 325 and 326. 
 HC-6’ H3CC-7’ HC-3’a HC-1’α HC-1’β H3CC-4’a H3CC-4’
326 2907.5 880.1 2860.6 1206.5 1030.3 709.7 1001.2 
325 2915.7 931.9 2848.0 1128.9 995.2 708.3 995.2 
δS - δR -8.2 -51.8 +12.6 +77.6 +35.1 +1.4 +6.0 
 ΔδSR < 0 (L2) ΔδSR > 0 (L1) 
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L1 = HC-3’a, HC-1’α, HC-1’β, H3CC-4’a, H3CC-4’ 
L2 = HC-6’, H3CC-7’ 
 
Figure 16. Assignment of the absolute configuration of 323 by NMR. 
 
The results in Table 7 clearly show that HC-6’ and H3CC-7’ have negative 
value ΔδRS and therefore belong to the L2 substitute (see Figure 16). The 
remaining protons all show positive value ΔδSR and belong to the L1 
substituent. Thus, the absolute configuration of 323 prepared from 
(R)-BINOL catalyzed Diels-Alder reaction of 105 and 106 is as illustrated. 
This result was confirmed by the X-ray analysis of 325 (Figure 17).   
 
Figure 17. X-ray structure for 325. 
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2.3 New route to the 5-6-6 tricyclic intermediate 
2.3.1 Introduction 
As in the racemic case,50 the enaniomerically enriched Diels-Alder adduct 
108 (>93%ee) underwent a photochemical [ 2 + 2 ] cycloaddition reaction 
with allene to give 327 as a 3 : 1 mixture of regioisomers, which was further 
hydrolyzed with TFA to give a 3:1 mixture of the known triketones50 110 and 
109, respectively. 
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An objective of the second generation synthesis was to develop a more 
direct synthesis of 115 from 110 by reducing the number of functional group 
transformations used in the original route (see Scheme 17). To convert the 
hydrolyzed photoadduct 110 into 115 (Scheme 62), three issues must be 
addressed: i) cyclobutane ring has to be transform into the cyathin five 
membered A-ring; ii) stereoselective reduction of the carbonyl group on 
C-ring has to be developed; iii) epimerization of the B,C-ring junction from 
cis to trans (Scheme 61).  
In the racemic route, the first issue was addressed by: i) chemoselective 
epoxidation; ii) addition of thiophenoxide to effect epoxide ring opening and 
retro-aldol; iii) aldol cyclization; iv) desulfurization (Scheme 17). It was 
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speculated that this overall transformation could be improved by using a 
more direct approach involving a Markovnikoff hydration of the exocyclic 
alkene. The resulting alcohol would then undergo a retro-aldol 
fragmentation of the cyclobutane moiety to give the methyl ketone 330, that, 
in turn, could give the desired 5-membered ring (i.e., 341) by the aldol-type 
cyclization. This overall transformation could be improved by using a more 
direct approach. This approach would shorten the previous route by two 
steps by avoiding the introduction and removal of the sulfide. 
The second required transformation was previously achieved by: i) a chemo 
and stereoselective reduction of the enone carbonyl in 110; ii) the eventual 
inversion of the configuration of the resulting alcohol by a Mitsunobu 
reaction; iii) hydrolysis of the Misunobu ester product (see Scheme 17). A 
more direct approach would involve reduction of the enone carbonyl with 
the desired stereoselectivity (e.g. 330); shortening the route by two steps. 
The isomerization of the 6,6-ring junction from cis to trans was efficiently 
achieved by treatment of 114 with NaOH as the equilibrium strongly favors 
115 (see Scheme 16). By using the same strategy, compound 341 should 
be easily converted into 115. 
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The presence of the enone in 110 was envisaged to facilitate the desired 
chemoselectivity. Thus, chemoselective reduction of the enone carbonyl 
should be possible because it is the least sterically hindered and is the most 
basic (i.e. more susceptible to an electrophilic reducing agent). Similarly, 
the exocyclic double bond in 110 is the most nucleophilic and should be 
more reactive than the enone towards acid-catalyzed hydration. Obbiously, 
the above reasoning dictates that olefin hydration should preceed carbonyl 
reduction.   
2.3.2 Markovnikov hydration of the exocyclic olefin in 110 
Initially, compound 110 was treated with Hg(ClO4)2 in wet acetone (5% H2O 
v/v) to give 330 in moderate yield (<50%) (Scheme 62). Attempts to 
optimize the reaction by varying the amount of Hg (II) salt, the concentration, 
and reaction time were not succesful. In most cases, several unidentified 
side products were present along with the desired 330. One hypothesis was 
that the nucleophilic addition of water to the intermediate mercurinium ion 
was a slow step allowing other pathways to compete (e.g. rearrangement). 
After considerable optimization, the Hg (II)-mediated hydrolytic ring opening 
step was achieved in excellent yield in 1:3 acetone:water. 
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Typically, Hg(II)-mediated addition to alkene requires a stoichiometric 
amount of Hg(II) and a second reduction (or other) step to remove the Hg 
from the product (Scheme 64). It is noteworthy that the reaction of 110 to 
330 is catalytic in Hg(II). This is easily rationalized by comparing the 
reaction to a Hg(II)-catalyzed hydration of alkynes. In contrast to alkene, 
Hg(II) mediated hydration of alkynes give α-mecurio ketones intemediates 
that lose Hg(II) by tautomerisation followed by hydrolysis (Scheme 64). 
Similarly, hydration of 110 produces α-mecurio ketone after retro-aldol of 
the initial oxy-mercuration product (Scheme 63). 
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2.3.3 Stereoselective reduction of the enone carbonyl in 330 
The chemo- and stereo-selective reduction of tetraone 330 is the key 
reaction of the 2nd generation route to 114. To achieve chemoselective 
reduction of the enone carbonyl in 330 (the most basic) requires the use of 
an electrophilic reducing agent. Excellent chemoselectivity was obtained 
with 9-BBN as was observed previously46 in the reduction of 328. This 
reaction was expected to give the undesired alcohol 332, as predicted by 
the concave 3D structure of 330 (and 328). The reaction was attempted 
numerous times.   
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Figure 18. Model to explain the stereoselectivity of 9-BBN reduction of 330. 
Typically, reaction of 330 with 9-BBN followed by addition of KOH and 
heating under reflux produced the expected product 334 in low to modest 
yields. However, occasionally (but not reproducibly) the α-OH product 333 
was obtained in variable yield (max. 45%) under seemingly the same 
conditions that usually gave 334. 
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Because the direct formation of 333 would be a significant improvement 
over the previous route, I set out to thoroughly investigate this 9-BBN 
reduction. Several initial attempts were not successful; the undesired 334 
was the major product in all cases. The effect of concentration, temperature, 
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solvent, and the order of adding reagents were investigated without 
success. These results indicated that to facilitate understanding the origin 
of the occasional formation of 333, all the important intermediates needed 
to be characterized (i.e. 331 and 332). One hypothesis was that the α–OH 
product 331 was formed from 330 by a reaction that involved impurities in 
the commercial 9-BBN reagent. This might explain the irreproducible 
formation of 333 (the previously used bottle was exhausted and I was using 
a “new” bottle). To test this hypothesis, a better control of the quality of the 
9-BBN was required. The commercial reagent (0.5 M in THF) was purified 
by precipitation and the precipitate was recrystalized from DME. The 
resulting needle crystals were used to prepare a stock solution of 9-BBN in 
THF. With this high quality 9-BBN reagent in hand, several reactions were 
attempted. 
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The reaction of 330 with 9-BBN was quenched by addition of methanol 
followed by concentration and 1H NMR analysis. Surprizingly, in almost all 
of the reactions, 339 was the major product with only a small amount of 332 
being detected. The facile formation of 339 suggested that the hydroxyl 
group is perfectly positioned for addition to the carbonyl and even a weak 
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Lewis acid like methoxy-9BBN can catalyze the ketal formation. The 
β-alcohol 332 was the major product if the reaction of 330 with 9-BBN was 
quenched with H2O. Little or no 331 was detected. It’s worth noting that 332 
is an equilibrium mixture of three components. Two of the three 
components involve intramolecular ketal formation consistent with the facile 
formation of 339. Fractionation of the crude reaction mixture gave a low 
yield of 331 and 332 as well as 339. The relative amount of 331 was not 
increased by controlled introduction of O2 or protic species (H2O, MeOH) to 
the 9-BBN reagent. Mass recovery was low regardless of the selectivity. 
One explanation for the poor mass balance was that the product was not 
free from the boron reagent. Another hypothesis was that 331 or 332 or 
both were further reduced under the reaction conditions. However, it was 
difficult to address these questions because of the complicated 1H NMR 
spectrum of the crude product. An efficient protocol for analysis of the crude 
product was required.  
"α-OH"
KOH/MeOH
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336335  
 
In the initial attempt, the crude product from 9-BBN reduction of 330 was 
treated with a stoichiometric amount of base, followed by neutralization with 
HCl. The reaction mixture was concentrated to dryness and analyzed by 1H 
NMR. The amount of a new product, initially thought to be 331, seemed to 
have increased dramatically under these conditions. Subjecting this new 
product to KOH surprisingly gave 335. More careful examination of the 1H 
NMR spectrum of the new product revealed differences compared to the 
spectrum of authentic 331 and suggested the chloride 336. Structure 336 
was corroborated by HRMS and 13C NMR and further experiments 
supported this conclusion. When citric acid was used in the neutralization 
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step, 336 was not produced. Treatment of pure 332 (or 339) with HCl gave 
336 in high yield. 
The above experiments suggested that inversion of configuration of the OH 
group in 332 under acidic conditions was very facile. To take advantage of 
that chemistry, the plan was to quench the 9-BBN reduction with a strong 
acid whose conjugate base is a poor nucleophile in hopes of having H2O 
act as the nucleophile. Reaction of 332 with HClO4 clearly produced the 
elimination products 337 and 338 without evidence of 331 (Scheme 67). 
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Another possibility was to use a strong acid whose conjugate base is a 
good oxygen-based nucleophile. Treatment of 332 with trifluroacetic acid 
(TFA) gave 340 in good yield (Scheme 68). Treatment of 339 under the 
same conditions gave 340 in excellent yield. Mild hydrolysis of 340 with 
NaOH smoothly gave the desired 331. Reduction of 330 with 9-BBN was 
readily optimized to give 339 in high yield (1.5 equiv 9-BBN, -10°C; 
methanol quench; 94% yield). Treatment of 339 with TFA followed by dilute 
NaOH gave the desired 331 in 90% yield (82% from 330) 
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2.3.4 Formation of the A ring and the trans B-C ring junction 
With 331 in hand the next step required an aldol cyclization to form the 
five-membered A ring of the cyathins. Treatment of 331 with KOH in THF 
under reflux gave the cyclic products 341 and 342 in a 1:1 equilibrium ratio.  
Scheme 69 
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To shift the equilibrium towards the desired trans-fused product, reduction 
of the carbonyl group at C-7 to the β-OH was required. In the resulting 
product, the cis-fused diastereomer 114 is destabilized relative to 115 due 
to the increased 1,3-diaxial interactions (Figure 19). 
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Figure 19. cis-fused 114 be destabilized by 1,3-diaxial interactions 
 
Thus, a chemo- and stereoselective reduction of 341 and 342 was required. 
This was accomplished by treatment with NaBH4 using a procedure 
previously developed in the group.51 
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Reaction of the mixture of 341 and 342 with NaBH4 in a 1:1 mixture of 
CH2Cl2 and MeOH at -78 oC gave 114 and 115 as the only products 
(Scheme 70). This mixture was heated under reflux in methanolic NaOH for 
5 days to afford the desired trans-fused 115 in excellent yield.  
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2.4 Optimized route to the 5-6-7 tricyclic 
intermediate 103 
Transformation of 115 into the 5-6-7 tricyclic ring system present in 
cyathane diterpenes requires the deoxygenation of the now-redundant C-7 
OH group and ring expansion of the cyclohexene by oxidative cleavage of 
the olefin followed by aldol-type cyclization of the resulting keto-aldehyde. 
2.4.1 Deoxygenation of the B ring 
Scheme 71 
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Deoxygenation of the C-7 OH group was previously achieved by a 
sequential elimination/hydrogenation approach (Scheme 17).46 Diol 115 
was converted to 116 via selective benzoylation followed by mesylation 
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(Scheme 71). The elimination of the mesylate 117 required refluxing in 
toluene for forty hours in the presence of DBU. The product 118 was 
susceptible to isomerization under these conditions and up to 20% of the 
cis diastereomer 344 was formed during this time period. The two products 
were difficult to separate by chromatography. The cis-isomer 344 is much 
less reactive towards hydrogenation and could be isolated in pure form from 
an incomplete hydrogenation of a mixture of 118 and 334. Under more 
forcing conditions 344 was reduced to the cis ketone 345. 
Because isomerization only happens to the elimination product 118, a 
simple solution was to stop the reaction at 50% conversion and recycle the 
recovered 117. No more than 10% of isomerization of product was detected 
at this stage. A careful study of the reaction conditions indicated that the 
product 118 is isomerized much faster in the presence of protonated DBU, 
the byproduct of the elimination reaction, than with DBU alone. Based on 
this observation, the reaction was carried out at lower concentration with an 
excess of DBU. Under these conditions less than 5% isomerization to 344 
was detected. The chemoselective hydrogenation of the disubstituted olefin 
in 118 was achieved efficiently using Wilkinson’s catalyst to obtain 104. 
 
 
2.4.2 Ring expansion 
The next stage of the synthesis involved ring expansion of the cyclohexene. 
Considerable effort was devoted to optimizing this transformation. As 
previously,46 the cyclohexene double bond in 104 was selectively oxidized 
by treatment with O3 in presence of Sudan III as an indicator (Scheme 72). 
In the presence of TsOH, the resulting ketoaldehyde 121 underwent aldol 
cyclization with concomitant 1,2-migration of the benzoyl group to give 123 
along with significant quantities (3:1) of a side product 346 derived from 
simple hydrolysis of the benzoate group in 121.46 The cyclization reaction 
was very sensitive to the presence of water and various conditions (different 
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acids, solvents, drying protocols) were attempted to improve the yield of 
123. Optimal results were obtained with the use of dry TsOH in dry toluene 
in the presence of 5 Å molecular sieves at 50 °C, which gave 123 in 80% 
yield and with very little of the hydrolysis side product (<5%). All of the 
above work was conducted using a rather old jar (>30 years) of TsOH·H2O 
(slightly off-white flakes, Eastman); we were surprised to find that 
cyclization could not be effected using TsOH·H2O from a “new” bottle (white 
crystals, Aldrich). Although the source of this discrepancy is uncertain, after 
much experimentation we were able to reproduce the cyclization using new 
TsOH·H2O with 5% of H2SO4. Methylation of 123 by treatment with methyl 
iodide in the presence of freshly prepared Ag2O gave 103, completing the 
5-6-7 tricyclic ring system of the cyathins.  
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a O3, Sudan III; b TsOH, toluene, benzene; c Ag2O, MeI 
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2.5 Introduction of the isopropyl group 
Intermediate 103 possesses the ring system and stereochemistry present in 
the cyathin diterpenes. Completion of the cyathin skeleton requires 
introduction of a hydroxmethyl substituent at C-12 and an isopropyl group at 
C-3. Introduction of an isopropyl group or any branched alkyl group to the 
alpha position of an enone is always a challenging problem.148 In the case 
of 103 the substitution at the beta position of the enone makes this problem 
even more difficult. Several strategies were attempted. 
2.5.1 Claisen rearrangement approach 
Scheme 73 
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Hopkins reported the introduction of a 1-methyl-2-propenyl subsituent to the 
α-position of a cycloalkenone via Claisen rearrangement of the derived 
2-butenyl enol ether (Scheme 73). 149 In principle, a 1-methyl-2-propenyl 
substituent could be transformed into an isopropyl group by oxidative 
cleavage of the olefin followed by reduction. In previous work,47 the enone 
103 was converted to the methyl enol ether 124 under acidic conditions 
(Scheme 19).  It was speculated that a similar transformation would yield 
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compound 350, that in turn could undergo Claisen rearrangement to give 
the desired ketone 351. However, under the reported conditions,149 the enol 
ether 350 was never detected and only 103 was recovered. Additional 
experiments with changes in concentration, solvent, and stoichiometry were 
attempted without success.    
2.5.2 Cross-coupling approach 
Among the carbon-carbon bond-forming reactions, Pd catalyzed cross 
coupling reactions have recently gained prominence (Heck,150 Suzuki,151 
Stille,152 and Negishi153,154 reactions). For the synthesis of complex 
molecules, the Stille coupling is often superior, displaying high selectivity 
and broad scope.152,155 Consequently, I considered introducing the 
isopropyl substituent directly to 103 by a cross-coupling reaction of the 
corresponding iodide 356 (Scheme 74). 76  
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O O
I
O
Py/I2 Pd
0
SnBu3
353 354 355  
OMe
O
H
OBzO
OMe
O
H
OBzO
I
I
I
103
358
I2, Py
TMSN3
OMe
O
H
OBzO
I 356
+30%
OMe
O
H
OBzO
357
1 : 3
 
Treatment of cycloalkenones with pyridine/iodine is the most acceptable 
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and general preparative route to α-iodocycloalkenones.156 Considerable 
effort was directed at optimizing this protocol for 103. However, under 
various conditions the desired product 356 was not detected. An alternative 
approach, especially for β-substituted cycloalkenones, uses trimethylsilyl 
azide as the activating agent to generate a TMS enol ether in situ, and this 
reactive intermediate undergos iodination.157 Treatment of 103 with 
trimethylsilyl azide and then with a mixture of iodine and pyridine 
sequentially in dichloromethane gave a 1:3 mixture of iodide 356 and 
triiodide 358 in low yield (Scheme 74). The amount of 356 obtained by this 
procedure was too low to permit an investigation of the cross-coupling 
reaction. However, because the triiodide 358 potentially can be converted 
to iodide 356, this approach still remains attractive and further investigation 
is warranted. 
 
2.5.3 Grignard addition approach  
Recently, the Ready158 group reported a copper-catalyzed reaction of 
organozinc halides with α-chloroketones, that enables the introduction of 
primary and secondary alkyl groups adjacent to a ketone carbonyl (e.g., 
359 to 360). 
O
Cl
O
iPrMgCl
CuCl
ZnCl2
359 360  
 
To incorporate this direct alkylation approach into the synthetic route, the 
preparation of α-chloroketone 361 in reasonable yield was required 
(Scheme 76). The synthesis of 361 started with cohalagenation of the 
dienol ether 124 with NCS and methanol to give a mixture of 361 and 362. 
Treatment of the mixture with aq. HCl gave the desired α-chloroketone 361 
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as a 3:1 mixture of two diastereomers. Following the reported protocol, the 
desired 141 could not be prepared from 361 (under conditions that worked 
well for 359). Only the dechlorinated ketone was recovered from the 
reaction.  
Scheme 75 
OMe
O
H
OBzO
OMe
MeO
OBzO
NCS
MeOH
103 124  
OMe
O
OBzO
Cl
MeO
OMe
OBzO
MeO Cl 3 : 1
HCl
361
OMe
O
OBzO
iPrMgCl
CuCl
ZnCl2 141
3 : 1
362  
 
 
2.5.4 Optimization of the radical cyclization approach 
After the Claisen and cross-coupling strategies failed, I decided to optimize 
the previously developed radical cyclization approach. The ketone 103 was 
converted to the enol ether 124 upon treatment with trimethyl orthoformate 
and 3% methanolic HCl (Scheme 77). Subjecting compound 124 to 
propargyl alcohol in presence of NBS at -78 oC provided the bromo-ketal 
125. Control experiments suggested that the bromo-ketal 125 was not 
stable to propargyl alcohol at room temperature. The major decomposition 
product was tentatively assigned structure 364. Under the subsequent 
radical cyclization conditions, the side product 364 is converted back to the 
enol ether 124. The simple solution is a quick work up including 
concentration of the crude product from benzene to remove the propargyl 
 100
alcohol. The resulting crude bromo-ketal 125 was used in the radical 
cyclization step without further purification. Treatment of the crude 125 with 
Ph3SnH in degassed benzene (0.02 M) under reflux gave 126 in 66% 
overall yield from 103.  
Scheme 76 
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a HC(OMe)3, 3% HCl, MeOH; b Propargyl alcohol, NBS; c Ph3SnH 
 
Compound 126 possessed the desired isopropyl three carbon unit at the 
correct position, albeit in a masked form. To complete the total synthesis of 
a cyathin diterpenoid would require some functional group manipulations on 
compound 126 in order to unmask the isopropyl group. Direct hydrolysis of 
126 under acidic conditions led only to the formation of the energetically 
favorable furan. Hence, saturation of the exocyclic double bond was 
required to prevent the aromatization. Hydrogenation of 126 over Pd-C 
gave 127 in good yield (Scheme 78). 
Attempted hydrolysis of 127 was difficult because of its facile isomerization 
to 131, a compound that proved to be intractable to further desired synthetic 
transformations (see section 1.4.4 and Scheme 19). Hydrolysis of the ketal 
127 to the desired 128 was previously achieved by treatment with 
 101
pyridinium p-toluenesulfonate (PPTS) in aqueous acetone for fourteen days. 
To shorten this long-term process, a variety of acids were investigated. In 
most cases, 131 was the only product. Finally, hydrolysis of 127 with 
Amberlyst in 7.5% aqueous acetone at room temperature for 10 h gave the 
desired 128 in 85% yield. In CDCl3 solution, 128 was a 1.5:1 mixture of the 
ring-chain tautomers 128a and 128b, respectively. 
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a. H2, Pd-C; b. Amberlyst, acetone, H2O 
 
With compound 128 in hand, it was of interest to pursue derivatization of the 
hydroxyl functionality that would eventually lead to the desired 
deoxygenation product. Previous studies had established the feasibility of 
converting 128 into iodide 140 by reaction with Ph2PCl followed by I2 
(Scheme 79). However this reaction was very capricious and I undertook a 
detailed study in an effort to optimize the process.   
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a. ClPPh2, Pyr; b. O2, H2O; c. I2, Pyr, ClPPh2; d. Amberlyst, H2O, Acetone; e. I2, Pyr; f. H2, 
Pd black, BaCO3 
 
This reaction is highly sensitive to moisture and oxygen. Isomerization 
product 131 and oxidation product 370 are the two major side products. 
Treatment of substrate 128 with Ph2PCl and I2 simultaneously, gave diene 
368 is the only product. This product was also observed in the sequential 
reaction if the phosphenyation was incomplete. Fortunately, 368 can be 
converted back to starting material 128 by hydrolysis in acetone. Under 
optimized conditions, iodide 140 was obtained in 70% yield from 128. 
Reduction of 140 with H2 over Pd-C gave α-isopropylketone 141.    
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2.6 Synthesis of cyathin A3 
Scheme 79 
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a NaOH/MeOH, reflux; b NMO, TPAP, MS-4A; c Tf2O, TTBP; d HCO2H, Et3N, Pd(OAc)2, 
DMF, PPh3 
 
Treatment of 141 with NaOH in MeOH resulted in hydrolysis of the 
benzoate ester with concomitant isomerization of the double bond into the 
required position to give 370. This isomerization reestablished the desired 
trans 6-7 ring fusion. The presence of the transannular acetal within the 
seven-membered ring makes the cis-fused diastereomer impossibly 
strained. To avoid protection and deprotection steps, 370 was directly 
oxidized to diketone 102 with tetrapropylammonium perruthenate (TPAP) 
and N-methylmorpholine (NMO)56. Selective deoxygenation of the 
cyclopentenone carbonyl was achieved by reaction of 102 with triflic 
anhydride (Tf2O) in the presence of 2,6-di-tert-butyl-4-methylpyridine57 to 
chemoselectively give the dienol triflate, which was reduced to 
cyclopentadiene 142 by Pd catalyzed reaction with HCO2H/Et3N.159  
Finally, the selective hydrogenation of the diene 142 was achieved by using 
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Pd-C. Introduction of the vinyl hydroxymethyl group was achieved by Pd 
catalyzed carbonylation of the vinyl triflate 373 derived from ketone 372 
followed by DIBAL-H reduction of the resulting ester 374 to give cyathin A3 
methyl ketal (-)-375 (50% from 372). Spectral data (1H and 13C NMR, [α]D, 
IR, MS) for (-)375 closely matched previously reported data3. Hydrolysis of 
375 to cyathin A3 1 (a mixture of hydroxy ketone and hemiacetal tautomers) 
proceeded readily in THF solution on exposure to aqueous HClO4. 
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2.7 Conclusions 
The goal of my thesis research was to establish an enantioselective 2nd 
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generation synthetic route to cyathane diterpenes. Most of the objectives 
were achieved:  
Objective 1: Develop an enantioselective version of the first Diels-Alder reaction.   
O
O
+
OTMS
TMSO
O
O
OTMS
OTMS
H
106 105 108
Ti(IV) / BINOL
MS-4A
Additive
(Mg, SiO2)
90%, 95%ee  
The enantioselective Diels-Alder reaction of 2,5-dimethylbenzoquinone 
(106) with Danishefsky type diene (105) is effectively catalyzed by Mikami’s 
catalyst modifed by addition of Mg powder and silica gel to give adduct 108 
in 90% yield and 95%ee. The absolute configuration of the Diels-Alder 
adduct 108 was determined by the X-ray analysis of the Mosher’s ester 325. 
Thus, the preparation of 108 with the desired absolute configuration for 
synthesis of cyathins requires the catalyst derived from (R)-BINOL. This is 
the first example of an enantioselective Diels-Alder reaction both of quinone 
(106) and of a Danishefsky-type diene (e.g. 105). 
Objective 2: Establish a more direct route from 110 to 115. 
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a) Hg(ClO4)2, acetone:H2O=1:3; b) 9-BBN; c) i. TFA, ii.NaOH. 
 
The more direct transformation from 110 to 330, involving a Markovnikoff 
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hydration of the exocyclic alkene followed by a retro-aldol fragmentation of 
the cyclobutane moiety, was accomplished by oxymercuration. Selective 
reduction of 330 was achieved with 9-BBN. The configuration of the initially 
formed β-OH product 332 was inverted on workup with trifluoroacetic acid 
and sodium hydroxide to give the desired α-OH product 331. 
 
Objective 3: Develop a more direct approach to introduce the isopropyl group. 
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Attempts to introduce the isopropylgroup via Claisen rearrangement 
approach and cross-coupling approach was not successful because I was 
unable to prepare either the enol ether 350 or the iodide 356. Following the 
reported protocol, the desired 141 could not be prepared from 361. Only the 
dechlorinated ketone was recovered from the reaction. Consequently, the 
previously developed route to 141 via radical cyclization was extensively 
optimized. 
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Objective 4: Establish a synthetic route to cyathin A3 
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Selective reduction of conjugated diene 142 was achieved by a mild 
hydrogenation catalyzed with palladium on carbon and this method 
potentially can be used to convert allocyathin B2 (10) into cyathin A3 (1). An 
enantioselective total synthesis of (-)-cyathin A3 (1) has been achieved in 
28 steps (0.65% overall yield).  
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Because cyathin A3 (1) is easily transformed into cyathin B3 (2), allocyathin 
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B3 (3), cyathin C3 (4), neoallocyathin A4 (7), cyathin B2 (9) and allocyathin 
B2 (10), this route also constitutes a formal synthesis of these natural 
products. Now envisioned in our laboratory is the development of a new 
access to cyathin A4 (5), which is surmised to be possible via an 
intermediate prepared in this synthesis (e.g. 128 and 376).  
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3. Experimental  
3.1 General Methods 
All solvents were distilled prior to use. Anhydrous solvents were distilled 
under an argon atmosphere as follows: Tetrahydrofuran (THF) and ether 
from benzophenone sodium ketyl; CH2Cl2 and toluene from CaH2; MeOH 
from Mg(OMe)2; Et3N and TiCl4 were distilled from CaH2.  All experiments 
involving air- and/or moisture-sensitive compounds were conducted in 
ovendried round-bottom flasks capped with rubber septa, and attached via a 
needle and connecting tubing to an argon manifold equipped with mercury 
bubbler (ca. 5 mm positive pressure of argon). Low temperature baths were 
ice/water (0°C) and CO2(s)/acetone (-78°C). Reaction temperatures refer to 
that of the bath. 
Preparative thin layer chromatography (PTLC) was carried out on glass 
plates (20×20 cm) precoated (0.25 mm) with silica gel 60 F254. Materials 
were detected by visualization under an ultraviolet lamp (254 nm) and/or by 
cutting a 1 cm vertical strip from the plate and wetting this strip with a 
solution of phosphomolybdic acid (5%) containing a trace of ceric sulfate in 
aqueous sulfuric acid (5% v/v), followed by charring on a hot plate. 
Concentration refers to removal of volatiles at water aspirator pressure on a 
rotary evaporator followed by evacuation at 0.5-1 torr obtained with a 
vacuum pump. Unless otherwise noted, all reported compounds were 
homogeneous by thin layer chromatography (TLC) and by NMR. Flash 
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column chromatography (FCC) was performed according to Still160 et al. with 
Merck Silica Gel 60 (40-63 μm). Medium pressure chromatography (MPC) 
was performed as reported by Taber.161 Dry flash column chromatography 
was performed according to Harwood.162 All mixed solvent eluents are 
reported as v/v solutions.  
High resolution mass spectra (HRMS) and low resolution mass spectra 
(LRMS) were obtained on a VG 70E double focussing high resolution 
spectrometer; only partial data are reported. Electron impact (EI) ionization 
was accomplished at 70 eV and chemical ionization (CI) at 50 eV with 
ammonia as the reagent gas; only partial data are reported. Infra red (IR) 
spectra were recorded on a Fourier transform interferometer using a diffuse 
reflectance cell (DRIFT); only diagnostic and/or intense peaks are reported. 
Unless otherwise noted, NMR spectra were measured in CDCl3 solution at 
500 MHz for 1H NMR and 125 MHz for 13C NMR. Signals due to the solvent 
(13C NMR) or residual protonated solvent (1H NMR) served as the internal 
standard: CDCl3 (7.27 δH, 77.23 δC); CD3OD (3.31 δH, 49.15 δC); C6D6 
(7.16 δH, 128.39 δC). The 1H NMR chemical shifts and coupling constants 
were determined assuming first-order behavior. Multiplicity is indicated by 
one or more of the following: s (singlet), d (doublet), t (triplet), q (quartet), m 
(multiplet), br (broad), ap (apparent); the list of coupling constants (J) 
corresponds to the order of the multiplicity assignment. In keeping with the 
typical digital resolution obtained (ca. 0.25Hz/pt), couplings constants (J) 
are reported to the nearest 0.5 Hz. The 1H NMR assignments were made on 
the basis of chemical shift and multiplicity and were confirmed, where 
necessary, by 1D homonuclear decoupling, 2D 1H/1H homonuclear shift 
correlation (COSY) and/or 1D NOE experiments. The 13C NMR 
assignments were made on the basis of chemical shift and multiplicity as 
determined by J-modulation and were confirmed, where necessary, by 2D 
1H/13C one bond correlation (HSQC) and 2D 1H/13C multiple bond correlation 
(HMBC) experiments. 
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Ag2O,163 TiCl2(OiPr)2,164,165  quinone 10648,49 and diene 10550 were 
prepared by known procedures. All other reagents were commercially 
available and, unless otherwise noted, were used as received.  
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3.2 Experimental procedures and spectral data 
(3aR,5aS,9S,10aS)-3,3a,4,5,5a,9,10,10a-Octahydro-9-hydroxy-8-(hydro
xymethyl)-3a,5a-dimethyl-1-(1-methylethyl) cyclohept[e]inden-6(2H)- 
one (1a) 
(3aR,5aS,6S,9S,10aS)-2,3,3a,4,5,5a,6,9,10,10a-Decahydro-6-hydroxy- 
3a,5a-dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e]indene-8- 
methanol (1b) (Cyathin A3) a 
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Cyathin A3 methyl ketal 375 (7 mg) was dissolved in THF (1 mL) and 1M aq. 
perchloric acid (70 μL) was added and the solution was stirred at room 
temperature for 5 days after which time TLC showed only the desired 1. 
The solution was diluted with saturated aq. NaHCO3 and extracted with 
CH2Cl2. Evaporation of the solvent gave cyathin A3 (1, 5.5 mg, 89%) as an 
oil. ([α]D27 = -160; c = 0.5, MeOH) (lit.3 [α]D = -155; c = 0.26, MeOH) 
 
IR (KBr) νmax (cm-1): 3394, 1734, 1606. 
  
 
a The compound name is according to the Chemical Abstracts 
skeleton shown on the left. Spectral assignments are according to 
the cyathin numbering system as indicated on the structure shown 
above. 
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LRMS (EI), m/z (relative intensity): 318 ([M]+, 4), 303 (9), 191 (14), 175 (12), 
97 (36), 69 (100).  
 
HRMS m/z calcd. for C21H30O3: 318.2195; found: 318.2196 (EI). 
 
 
 
(3aR,5aS,6S,9S,10aS)-3,3a,4,5,5a,6,7,9,10,10a-Decahydro-6-methoxy- 
3a,5a-dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e]indene-2,8- 
dione (102) a 
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TPAP (25 mg, 0.071 mmol) was added to a stirred suspension of powdered 
4 Å molecular sieves (100 mg), N-methylmorpholine oxide (20 mg, 0.17 
mmol), and alcohol 370 (18 mg, 0.054 mmol) in dry CH3CN (4 mL). After 2 h, 
the mixture was concentrated and fractionated by FCC (20% ethyl acetate 
in hexane) to give 102 (16 mg, 89%). ([α]D27 = -120; c = 1.1, CH2Cl2) 
 
IR (KBr) νmax (cm-1): 1740, 1717 
.  
 
 
a The compound name is according to the Chemical Abstracts 
skeleton shown on the left. Spectral assignments are according to 
the cyathin numbering system as indicated on the structure shown 
above. 
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1H NMR (500 MHz CDCl3) δ: 4.35 (1H, m, HC-11), 3.42 (3H, s, H3C-15), 
2.94 (1H, qq, J = 7, 7 Hz, HC-18), 2.70~2.80 (2H, m, HC-5, 13), 2.56 (1H, d, 
J = 18.5 Hz, HC-13), 2.47 (1H, ddd, J = 4, 13.5, 13.5 Hz, HC-10), 2.22 (1H, 
d, J = 18.5 Hz, HC-1), 2.16 (1H, d, J = 18.5 Hz, HC-1), 1.97 (1H, ddd, J = 2, 
4, 13 Hz, HC-10), 1.25~1.85 (4H, m, H2C-7, 8), 1.23 (3H, d, J = 7 Hz, 
H3C-19/20), 1.20 (3H, d, J = 7 Hz, H3C-19/20), 1.20 (3H, s, H3C-16/17), 
1.09 (3H, s, H3C-16/17).  
 
13C NMR (125 MHz, CDCl3) δ: 215.2, 208.3, 173.2, 143.5, 109.5, 80.9, 
52.7, 49.8, 45.5, 39.9, 39.3, 39.2, 36.0, 28.2, 27.9, 26.6, 26.1, 20.5, 20.2, 
12.8.  
 
LRMS (EI), m/z (relative intensity): 332 ([M]+, 30), 204 (100), 189 (51), 176 
(26), 162 (28), 149 (24), 127 (12), 114 (13).  
 
HRMS m/z calcd. for C20H28O4: 332.1988; found: 332.1984 (EI). 
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(3aR,5aS,6S,8R,9S,10aS)-8-(Benzoyloxy)-3a,4,5,5a,6,7,8,9,10,10a- 
decahydro-6-methoxy-3a,5a-dimethyl-6,9-epoxycyclohept[e]inden- 
2(3H)-one (103) a 
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Freshly prepared Ag2O163 (500 mg, 2.16 mmol) was added to a stirred 
solution of 123 (702 mg, 1.77 mmol) in MeI (10 mL). After 48 h, the reaction 
mixture was diluted with ethyl acetate and filtered through Celite. The 
combined filtrate and washings were concentrated and fractionated by FCC 
(20% ethyl acetate in hexane) to give 103 (569 mg, 81%). Spectral data for 
103 closely matched that reported previously.46 ([α]D27 = -120; c = 1.0, 
CH2Cl2) 
 
 
 
 
 
 
 
 
 
a The compound name is according to the Chemical Abstracts 
skeleton shown on the left. Spectral assignments are according to 
the cyathin numbering system as indicated on the structure shown 
above. 
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 116
(3aR,5S,5aS,8S,9aS)-8-(Benzoyloxy)-3,3a,4,5,5a,8,9,9a-octahydro- 
3a,5a,6-trimethyl-2H-benz[e]inden-2-one (104) 
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104 
 
A solution of 118 (1.22 g, 3.48 mmol) and (Ph3P)3RhCl (576 mg, 0.623 
mmol) in degassed benzene (60 mL) was stirred under a H2 atmosphere 
(ca. 3 bar) for 72 h. The mixture was concentrated and fractionated by FCC 
(30% ethyl acetate in hexane) to give 104 (1.14 g, 94%). Spectral data for 
104 closely matched that reported previously.46 ([α]D27 = -67; c = 1.1, 
CH2Cl2) 
 
 
 
(4aR,5R,8aR)-4a,5,8,8a-Tetrahydro-2,4a,5-trimethyl-5,7- 
bis[(trimethylsilyl)oxy]-1,4-naphthalenedione (108)  
O
O
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108 
 
To 4Å molecular sieves (Aldrich, 5-6% H2O, particle size 2-3μ, 8.0 g) was 
added a solution of (R)-2,2'-dihydroxy-1,1'-binaphthyl (114 mg, 0.40 mmol) 
in DCM (20 mL) and a solution of TiCl2(OiPr)2 in toluene (0.30 M; 1.3 mL, 
0.4 mmol) at room temperature. The reddish brown reaction mixture was 
stirred for 1 h and then a solution of 2,5-dimethyl-p-benzoquinone (106; 1.0 
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g, 7.3 mmol) in CH2Cl2 (10 mL) was added. After 1 h at room temperature, 
2,4-bistrimethylsilyoxy-1,3-pentadiene (105 as a 1:1 mixture of 
stereoisomers; 16 g, 65 mmol), magnesium powder (80 mg) and silica gel 
(EMD, 230-400 mesh powder, 160 mg)  were added. The reaction mixture 
was concentrated to remove all the DCM. The remaining mixture was 
stirred at room temperature until complete conversion of 106 was indicated 
by TLC [deactivated silica gel (Et3N), hexane:EtOAc 4:1] (ca. 24h). The 
reaction mixture was diluted with hexane (20 mL) and Et3N (1 mL). After 
stirring for 0.5 h at room temperature, the reaction mixture was filtered 
through a Celite pad. The filtrate was concentrated to dryness and the 
residue fractionated by bulb to bulb distillation (60 oC/0.025 torr) to remove 
the volatile diene, and leave 108 (2.8 g; ca. 95 % purity; ca 95 % yield; 93% 
ee). A total of 75 g of 108 was prepared from several similar experiments 
(1-5 g of 106). Spectral data for 108 closely matched that reported 
previously for racemic material.50 The ee of 108 was determined by 1H 
NMR analysis of hydrolyzed product 297 (see page 129). 
 
 
 
(2aR,3aS,7aS,8aR)-1,2,2a,3a,7a,8a-Hexahydro-2a,7,7a-trimethyl-2- 
methylenecyclobuta[b]naphthalene-3,5,8(4H)-trione (109) 
(2aR,3aR,7aR,8aS)-1,2,2a,3a,7a,8a-Hexahydro-2a,7,7a-trimethyl-1- 
methylenecyclobuta[b]naphthalene-3,5,8(4H)-trione (110) 
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109   110              
 
Trifluoroacetic acid (1 mL) was added to a stirred solution of the crude 
photoadducts 327 (10 g) and MeOH (20 mL) in CH2Cl2 (180 mL). After 2 h, 
 118
toluene (5 mL) was added and the mixture was concentrated to give crude 
product (6.8 g; 110 : 109 was 3:1 by 1H NMR) that was purified by FCC 
(50% ethyl acetate in hexane) to give a 3:1 mixture of 110 and 109, 
respectively, (5.3 g, 85% from 327). With similar experiments, a total of 88 g 
of 327 was converted to 46 g of 109 and 110. Spectral data for the mixture 
of 110 and 109 closely matched that reported previously.50 
 
 
 
(3aS,5R,5aR,8S,9aR)-3,3a,4,5,5a,8,9,9a-Octahydro-5,8-dihydroxy- 
3a,5a,6-trimethyl-2H-benz[e]inden-2-one (115) 
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115 
 
The crude 1:1 mixture of diols 343 and 115 (2.16 g) obtained by NaBH4 
reduction of the mixture of diones 341 and 342 was taken up in MeOH (150 
mL) and NaOH (2 g, 50 mmol) was added and the resulting solution was 
heated under reflux for 5 days. The cooled reaction mixture was made 
slightly acidic (pH 6) by addition of 6 N HCl aq. and then NaHCO3 (2 g) was 
added. The mixture was concentrated to dryness and the resulting solid 
was extracted with 30% MeOH in CH2Cl2 (×3). Concentration of the 
combined extracts provided 115 (1.82 g, 84%). ([α]D27 = -110; c = 0.9, 
CH2Cl2). The spectral data for 115 closely matched that reported 
previously.50 
 
 
 119
(3aR,5S,5aS,8S,9aS)-8-(Benzoyloxy)-3,3a,4,5,5a,8,9,9a-octahydro-5- 
hydroxy-3a,5a,6-trimethyl-2H-benz[e]inden-2-one (116) 
 
OBz
O
H
OH
1
2
3
4
9
5
6
7
89a
5a
9b
3a
 
116 
 
PhCOCl (2.3 mL, 2.8 g, 20 mmol), Et3N (4.6 mL, 3.3 g, 33 mmol), and 
DMAP (92 mg, 0.75 mmol) were added to a solution of 115 (1.82 g, 6.94 
mmol) in CH2Cl2 (80 mL). The reaction mixture was kept at 4 °C for 16 h 
and then MeOH (20 mL) was added. After 30 min, the solution was 
concentrated and the resulting oil was fractionated by MPC (eluting first 
with CH2Cl2 then with 75% ethyl acetate in hexane) to give 116 (2.22 g, 
91%). Spectral data for 116 closely matched that reported previously.46 
([α]D27 = -110; c = 1.1, CH2Cl2) 
 
 
 
(3aR,5S,5aS,8S,9aS),8-(Benzoyloxy)-3,3a,4,5,5a,8,9,9a-octahydro- 
3a,5a,6-trimethyl-5-[(methylsulfonyl)oxy]- 2H-benz[e]inden-2-one (117) 
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Methanesulfonyl chloride (3.6 mL, 5.2 g, 44 mmol) was added over 15 h via 
a syringe pump to a stirred solution of 116 (2.22, 6.06 mmol) in dry pyridine 
 120
(200 mL) at 50 °C under argon. The mixture was concentrated from toluene 
and then diluted with ethyl acetate, and washed sequentially with dilute aq. 
HCl, satd. NaHCO3 and brine, dried over Na2SO4, concentrated, and 
fractionated by FCC (25% ethyl acetate in hexane) to give 117 (2.53 g, 
93%). ([α]D27 = -46; c = 1.3, CH2Cl2) Spectral data for 117 closely matched 
that reported previously.46 
 
 
 
(3aR,5aR,8R,9aR)-8-(Benzoyloxy)-3,3a,5a,8,9,9a-hexahydro-3a,5a,6- 
trimethyl-2H-benz[e]inden-2-one (118) 
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Freshly distilled DBU (13 mL, 13 g, 87 mmol) was added to a stirred 
solution of 117 (2 g, 4.5 mmol) in toluene (500 mL) under argon and the 
mixture was heated under reflux. Reaction progress was monitored by TLC 
(50% ethyl acetate in hexane) and after 30–40 h, 117 was no longer 
present. The mixture was diluted with ethyl acetate and washed 
sequentially with dilute aq. HCl, satd. NaHCO3 and brine, dried over 
Na2SO4, concentrated, and fractionated by FCC (30% ethyl acetate in 
hexane) to give 118 as a colorless oil (1.27 g, 81%). Spectral data for 118 
closely matched that reported previously.46  
 
 
 
 
 121
(αR,4R,5R,7aS)-5-acetyl-α-(Benzoyloxy)-2,4,5,6,7,7a-hexahydro-5,7a- 
dimethyl-2-oxo-1H-Indene-4-propanal (121) 
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A stream of ozone in air was bubbled through a solution of 104 (841 mg, 
2.40 mmol) and Sudan III (1 to 2 mg) in 10% methanolic dichloromethane 
(300 mL) at –78 °C until the red color was discharged. Argon was bubbled 
through the solution for 20 min (to remove excess O3) and then pyridine 
(0.3 mL) and dimethyl sulfide (1.5 mL) were added and the solution kept at 
4 °C (refrigerator) for 16 h. The mixture was concentrated from xylene (to 
remove pyridine and dimethyl sulfoxide) to provide essentially 
homogeneous ketoaldehyde 121 (918 mg, 99%). Spectral data for 121 
closely matched that reported previously.46 
 
 
 
 122
(3aR,5aS,6S,8R,9S,10aS)-8-(Benzoyloxy)-3a,4,5,5a,6,7,8,9,10,10a- 
decahydro-6-hydroxy-3a,5a-dimethyl-6,9-epoxycyclohept[e]inden- 
2(3H)-one (123) 
OH
O
H
OBzO
1
3
2
4 5
6
7
8
9
10 11
12
13
14
16
17
 
         123 
 
A solution of the ketaoaldehyde 121 (918 mg, 2.42 mmol) in benzene (450 
mL) was dried by concentration to a volume of ca. 300 mL via distillation 
under argon. Activated molecular sieves 5 Å (13.5 g; ca. 210 pellets) were 
added to this solution. A suspension of p-toluenesulfonic acid monohydrate 
(918 mg, 5.33 mmol) in toluene (240 mL) was heated under reflux in a 
modified Dean–Stark trap containing activated 5 Å molecular sieves. After 
45 min, the resulting dry TsOH solution was allowed to cool to room 
temperature and then was added to the above solution of ketoaldehyde 121 
and the reaction mixture was heated to 40 °C. After 48 h without stirring, the 
mixture was allowed to cool to room temperature and NaHCO3 (9 g) was 
added. After stirring for 20 min, the mixture was diluted with ethyl acetate 
(300 mL) and filtered. The combined filtrate and washings (20% MeOH in 
CH2Cl2) were concentrated and fractionated by FCC (30%–50% ethyl 
acetate in hexane) to give 123 (702 mg, 76.5 %). Spectral data for 123 
closely matched that reported previously.46 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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 123
(3aR,5aS,6S,8R,9S)-3,3a,4,5,5a,6,7,8,9,10-decahydro-2,6-dimethoxy- 
3a,5a-dimethyl-6,9-epoxycyclohept[e]inden-8-ol benzoate (124) 
 
1
3
2
4 5
6
7
8
9
10 11
12
13
14
16
17
OMe
MeO
OBzO
 
124 
 
A solution of 3% HCl in MeOH (4 mL, prepared by addition of AcCl to MeOH) 
was added to a solution of 103 (150 mg, 0.378 mmol) and trimethyl 
orthoformate (4.5 mL) in toluene (25 mL). After 1 h, toluene (8 mL) was 
added and the reaction mixture was concentrated to a volume of ca. 5 mL 
by distillation of the solvent at atmospheric pressure. The reaction mixture 
was concentrated under reduced pressure to give 103 (150 mg, 97%) that 
was essentially homogeneous by TLC and was used in the next step 
without further purification. Spectral data for 124 closely matched that 
reported previously.47,166 
 
 
 
 
 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are acc 
ording to the cyathin numbering system as indicated on the structure 
shown above. 
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 124
(1R,2R,3aS,5aR,6R,8S,9R)-1-bromo-1,2,3,3a,4,5,5a,6,7,8,9,10- 
dodecahydro-2,6-dimethoxy-3a,5a-dimethyl-2-(2-propynyloxy)-6,9- 
epoxycyclohept[e]inden-8-ol benzoate 
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A solution of N-bromosuccinimide (recrystallized from benzene; 90 mg, 
0.51 mmol) in CH2Cl2 (9 mL) was added to a stirred solution of the above 
crude 124 (150 mg) and distilled propargyl alcohol (0.90 mL, 0.86 g, 15 
mmol) in CH2Cl2 (6 mL) at –78 °C under argon. After 20 min, the reaction 
mixture was quenched by addition of 10% aq. Na2S2O3 and the cooling bath 
was removed. The mixture was diluted with CH2Cl2 and washed with aq. 
NaHCO3 and water, dried over MgSO4, and concentrated from benzene (15 
mL) to give the crude α-bromo acetal 125 (210 mg) that was used 
immediately without further purification. Spectral data for 125 closely 
matched that reported previously.47,166 
 
13C NMR (125 MHz, CDCl3) δ: 166.2, 140.8, 134.9, 133.1, 130.2, 129.6 
(x2), 128.4 (x2), 111.2, 108.1, 80.0, 79.2, 77.8, 74.0, 52.8, 51.0, 50.3, 49.7, 
47.4, 45.9, 40.2, 33.0, 32.6, 29.6, 27.4, 27.0, 19.7  
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(2R,3S,5R,5aR,7aS,8aR,11aR)-1,2,3,4,5,5a,6,7,7a,8,8a,10,11,11a- 
Tetradecahydro-5,8a-dimethoxy-5a,7a-dimethyl-11-methylene-2,5- 
epoxycyclohept[6,7]indeno[2,1-b]furan-3-ol benzoate (126) 
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Ph3SnH (200 mg, 0.57 mmol) and AIBN, (12 mg, 0.075 mmol) were added 
to a solution of the crude 125 (210 mg) in freshly distilled, degassed 
benzene (25 mL) under argon and the reaction mixture was immersed in an 
oil bath preheated to 80 °C. After 2 h, the mixture was concentrated and 
fractionated by MPC (10%–60% ethyl acetate in hexane) to give 126 (102 
mg, 66% yield from 103). Spectral data for 126 closely matched that 
reported previously.47,166 
 
 
 
 
 
 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(2R,3S,5R,5aR,7aS,8aR,11S,11aS)-1,2,3,4,5,5a,6,7,7a,8,8a,10,11,11a- 
Tetradecahydro-5,8a-dimethoxy-5a,7a,11-trimethyl-2,5- 
epoxycyclohept[6,7]indeno[2,1-b]furan-3-ol benzoate (127)  
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A suspension of 5% Pd/C (75 mg) and 126 (102 mg, 0.215 mmol) in ethyl 
acetate (15 mL) was stirred under H2 (3 bar). After 2 days, the mixture was 
filtered and the combined filtrate and benzene washings were concentrated 
and fractionated by FCC (20% ethyl acetate in hexane) to give 127 (85 mg, 
84% yield). Spectral data for 127 closely matched that reported 
previously.47,166 
  
 
 
 
 
 
 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(2R,3S,5R,5aR,7aS,8aR,11S,11aS)-2,3,4,5,5a,6,7,7a,8,10,11,11a- 
Dodecahydro-5-methoxy-5a,7a,11-trimethyl-2,5-epoxycyclohept 
[6,7]indeno[2,1-b]furan-3,8a(1H)-diol,3-benzoate (128a) 
(1R,3aR,5aS,6S,8R,9S)-8-(Benzoyloxy)-3,3a,4,5,5a,6,7,8,9,10- 
decahydro-1-[(1R)-2-hydroxy-1-methylethyl]-6-methoxy-3a,5a- 
dimethyl-6,9-epoxycyclohept[e]inden-2(1H)-one (128b) 
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128a,   128b  
 
Amberlyst  (50 mg) was added to a solution of 127 (85 mg, 0.187 mmol) in 
7.5% aqueous acetone (2 mL) and the mixture was allowed to stand at 
room temperature. After 10 h, the mixture was diluted with CH2Cl2 and, 
filtered. The combined filtrate and washings were dried over NaHCO3 and 
Na2SO4, concentrated, and fractionated by FCC (30% ethyl acetate in 
hexane) to provide recovered 127 (13 mg, 15%) and 128 (60 mg, 73%; 86% 
based on recovered 127) as a 1:1.5 mixture of the ring-chain tautomers 
128a and 128b, respectively. Spectral data for 128 closely matched that 
reported previously.47,166 
 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(1R,3aR,5aS,6S,8R,9S)-8-(Benzoyloxy)-3,3a,4,5,5a,6,7,8,9,10- 
decahydro-1-[(1R)-2-iodo-1-methylethyl]-6-methoxy-3a,5a-dimethyl- 
6,9-epoxycyclohept[e]inden-2(1H)-one (140) 
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140 
 
A solution of Ph2PCl (40 μL, 48 mg, 0.22 mmol) in dry toluene (0.4 mL) was 
added to a stirred solution of 128 (50 mg, 0.11 mmol) and pyridine (100 μL, 
98 mg, 1.24 mmol) in dry toluene (1 mL) at room temperature under argon. 
After 2 h, the reaction mixture was titrated with a solution of iodine (21 mg, 
0.083 mmol) in toluene (1 mL) to a yellow end point. After 1 h, the reaction 
mixture was concentrated and the residue was fractionated by FCC (10% 
ethyl acetate in hexane) to give the iodide 140 (43 mg, 70%).   
 
1H NMR (500 MHz CDCl3) δ: 7.5~8.1 (5H, Ar-H), 5.06 (1H, d, J = 7 Hz, 
HC-12), 4.51 (1H, d, J = 4 Hz, HC-11), 3.58 (1H, dd, J = 9, 9 Hz, HC-19), 
3.45 (3H, s, H3C-15), 3.40 (1H, br s, HC-3), 3.29 (1H, dd, J = 6.5, 9 Hz, 
HC-19), 2.68 (1H, m, HC-10), 2.48 (1H, m, HC-18), 2.42 (1H, dd, J = 7.5, 15 
Hz, HC-10), 2.25 (1H, d, J = 16 Hz, HC-1), 2.19 (1H, d, J = 16 Hz, HC-1), 
2.15 (1H, d, J = 15 Hz, HC-13), 2.12 (1H, d, J = 15 Hz, HC-13), 1.50~1.90 
(4H, m, H2C-7, 8), 1.29 (3H, s, H3C-17), 1.12 (3H, s, H3C-16), 0.91 (3H, d, J 
= 7 Hz, H3C-20). 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(1R,3aR,5aS,6S,8R,9S)-8-(Benzoyloxy)-3,3a,4,5,5a,6,7,8,9,10- 
decahydro-6-methoxy-3a,5a-dimethyl-1-(1-methylethyl)-6,9- 
epoxycyclohept[e]inden-2(1H)-one (141) 
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A suspension of BaCO3 (ca. 12 mg), Pd black (18 mg), and the iodide 140 
(43 mg, 0.076 mmol) in C6H6 (5 mL) was stirred under H2 (1 atm, 1 std atm 
= 101.325 kPa). After 7 h, the mixture was filtered through Celite and the 
combined filtrate and washings were concentrated to give 141 (28 mg, 
84%). ([α]D27 = -10; c = 2.0, CH2Cl2) Spectral data for 141 closely matched 
that reported previously.47,166 
 
 
 
 
 
 
 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(3aR,5aS,6S,9S,10aS)-4,5,5a,6,7,9,10,10a-Octahydro-6-methoxy-3a,5a-
dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e]inden-8(3aH)-one 
(142) 
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142 
   
To a mixture of triethylamine (0.42 mL, 3 mmol), palladium acetate (4 mg, 
0.02 mmol), and triphenylphosphine (10 mg, 0.04 mmol) in DMF (2 mL) was 
added 99% formic acid (0.075 mL, 2 mmol). This solution (0.16 mL) was 
added to the triflate 371 (16 mg, 0.034 mmol), and the reaction mixture was 
stirred at 60 oC under argon. After 1 h, the mixture was diluted with brine 
and extracted with ether. The combined organic layers were washed twice 
with brine, dried over Na2SO4, concentrated, and fractionated by FCC to 
give 142 (8 mg, 75%).  ([α]D27 = -70; c = 0.9, CH2Cl2) Spectral data for 142 
closely matched that reported previously.47,166 
 
 
 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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131 
(4aR,8aR),4a,5-Dihydro-3,8,8a-trimethyl-,1,4,6(8aH)-naphthalenetrione 
(297) 
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297 
 
Trifluoroacetic acid (0.1 mL) was added to a stirred solution of 108 (2.8 g; 
ca 95% purity) in MeOH (2 mL) and CH2Cl2 (18 mL). After 2 h, toluene (5 
mL) was added and the mixture was concentrated to give crude 297 that 
was purified by FCC (50% ethyl acetate in hexane) to give 297 (1.3 g, 81% 
from 106). ([α]D27 = -48; c = 1.0 CH2Cl2; 93%ee). Spectral data for 297 
closely matched that reported previously for racemic material.46  
 
 
Determination of ee of (-)-297 
The ee of (-)-297 was determined by 1H NMR analysis (0.1-0.2 M in CDCl3) 
in the presence of (S)-(+)-1-(9-anthryl)-2,2,2-trifluoroethanol (6-10 equiv) by 
integration of the peaks at δ1.97 (1H, d, J = 7 Hz, H3C-3, (-)-297) andδ
1.96 (1H, d, J = 7 Hz, H3C-3, (+)-297). Ratios > 30:1 were confirmed by 
comparison of the minor peak to the 13C satellite (0.55% assumed) of the 
major peak. 
 
 
132 
(4a'R,8a'R)-4',4a',7'-Trimethyl-1'H-spiro[[1,3]dithiolane-2,2'- 
naphthalene]-5',8'(4a'H,8a'H)-dione (322) 
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322 
 
p-Toluenesulfonic acid monohydrate (200 mg, 1.05 mmol) was added to a 
stirred solution of 308 (300 mg, 1.37 mmol) and ethanedithiol (150 mg, 1.60 
mmol) in acetic acid (3 mL). After stirring at room temperature overnight, 
ethyl acetate (20 mL) was added and the mixture was washed with 
saturated aq. sodium bicarbonate solution (×2), dried over sodium sulfate, 
and concentrated to give crude 322 that was fractionated by FCC (20% 
ethyl acetate in hexane) to give 322 (356 mg, 88%). ([α]D27 = -210; c = 1.0, 
CH2Cl2). 
 
IR (KBr) νmax (cm-1): 1681, 1627.  
 
1H NMR (500 MHz CDCl3) δ: 6.48 (1H, s, HC-6’), 5.73 (1H, s, HC-3’), 
3.18~3.39 (4H, , H2C-4,H2C-5), 2.34 (1H, dd, J = 2, 12 Hz, HC-1’), 2.28 (1H, 
dd, J = 12, 12 Hz, HC-1’), 1.98 (3H, s, H3CC-7’), 1.90 (3H, s, H3CC-4’), 1.38 
(3H, s, H3CC-4a’).  
 
13C NMR (125 MHz, CDCl3) δ:  201.6 (s, C-8’), 200.7 (s, C-5’), 148.1 (s, 
C-7’), 137.0 (s, C-4’), 136.6 (d, C-6’), 129.4 (d, C-3’), 64.6 (s, C-2), 57.0 (d, 
C-8’a), 52.0 (s, C-4’a), 44.7 (t, C-1’), 40.9 (t, C-4/5), 40.0 (t, C-4/5), 24.6 (q, 
CH3C-4’a), 21.1 (q, CH3C-4’), 16.3 (q, CH3C-7’) 
 
LRMS (EI), m/z (relative intensity): 294 ([M]+, 54), 266 (87), 233 (27), 201 
133 
(20), 198 (30), 170 (48), 138 (96), 96 (100).  
 
HRMS m/z calcd. for C15H18O2S2: 294.0748; found: 294.0744 (EI). 
 
 
 
(4a'R,8'R,8a'R)-8'-Hydroxy-4',4a',7'-trimethyl-8',8a'-dihydro-1'H- 
spiro[[1,3]dithiolane-2,2'-naphthalen]-5'(4a'H)-one (323) and 
(4a'R,8'S,8a'R)-8'-Hydroxy-4',4a',7'-trimethyl-8',8a'-dihydro-1'H- 
spiro[[1,3]dithiolane-2,2'-naphthalen]-5'(4a'H)-one (324) 
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     323     324 
 
NaBH4 (170 mg, 4.47 mmol) was added to a solution of 322 (400 mg, 1.36 
mmol) in 1:1 CH2Cl2–MeOH (100 mL) at –78 °C. After stirring at –78 °C for 
5 h, acetic acid (2 mL) was added and the reaction mixture was allowed to 
warm to room temperature. Concentration from toluene (×2) provided the 
crude alcohol that was fractionated by FCC (50% ethyl acetate in hexane) 
to give a 10:1 mixture of 323 and 324, respectively, (343 mg, 86%).  ([α]D27 
= -8; c = 0.3, CH2Cl2) 
 
IR (KBr) νmax (cm-1): 3441, 1661.  
 
1H NMR (500 MHz CDCl3) δfor 323: 5.76 (1H, s, HC-6’), 5.73 (1H, s, 
HC-3’), 4.91 (1H, m, HC-8’), 3.22~3.42 (4H, m, H2C-4/5), 2.55 (1H, m, 
HC-1’), 2.40 (1H, ddd, J = 2, 5.5, 13 Hz, HC-8’a), 2.02 (3H, s, H3CC-7’), 
2.01 (3H, s, H3CC-4’), 1.96 (1H, dd, J = 13, 13 Hz, HC-1’), 1.34 (3H, s, 
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H3CC-4’a). 
 
13C NMR (125 MHz, CDCl3) δfor 323: 201.1 (s, C-5’), 158.8 (s, C-7’), 
139.1 (s, C-4’), 129.0 (d, C-3’), 125.8 (d, C-6’), 69.2 (d, C-8’), 65.6 (s, C-2), 
50.2 (s, C-4’a), 49.2 (d, C-8’a), 40.6 (t, C-4/5), 40.0 (t, C-4/5), 37.9 (t, C-1’), 
22.0 (q, CH3C-4’), 20.5 (q, CH3C-4’a), 20.1 (q, CH3C-7’). 
 
LRMS (EI), m/z (relative intensity): 296 ([M]+, 40), 198 (51), 170 (25), 165 
(26), 138 (100), 123 (36), 106 (57), 98 (97).  
 
HRMS m/z calcd. For C15H20O2S2: 296.0905; found: 296.0909 (EI).  
 
 
 
(4a'R,8'R,8a'R)-4',4a',7'-Trimethyl-5'-oxo-4a',5',8',8a'-tetrahydro-1'H- 
spiro[[1,3]dithiolane-2,2'-naphthalene]-8'-yl 
(R)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (325) 
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325 
 
Oxalyl chloride (720 μL, 8.21 mmol) was added to a solution of 
(R)-(+)-MTPA (400 mg, 1.71 mmol) and DMF (113 mg, 1.55 mmol) in 
hexane (40 mL) at room temperature. A white precipitate formed 
immediately. After 0.5 h the mixture was filtered and concentrated (water 
aspirator). A solution of a 10:1 mixture of 323 and 324 (200 mg, 0.67 mmol), 
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Et3N (0.83 mL, 0.60 g, 6.0 mmol), and DMAP (117 mg, 0.96 mmol) in CHCl3 
(15 mL) was added to the residue. After 10 min, TLC of the mixture 
revealed complete conversion into the diasteromeric Mosher’s esters. 1M 
HCl was added and the reaction mixture was extracted with CH2Cl2 (3x). 
The combined organic layers were concentrated and fractionated by FCC 
(20% ethyl acetate in hexane) to give the titled ester (283 mg, 91%). ([α]D27 
= -71; c = 2.0, CH2Cl2) 
 
IR (KBr) νmax (cm-1): 2926, 1751, 1676, 1440, 1252, 1172, 1011. 
  
1H NMR (500 MHz CDCl3) δ: 7.51 (2H, Ar-H), 7.36~7.38 (3H, Ar-H), 6.18 
(1H, d, J = 5 Hz, HC-8’), 5.77 (1H, s, HC-6’), 5.63 (1H, s, HC-3’), 3.51 (3H, s, 
OMe), 3.16~3.33 (3H, , HC-4, HC-5), 2.90 (1H, ddd, J = 5, 9, 11.5 Hz, HC-4 
/ HC-5), 2.58 (1H, ddd, J = 2, 5.5, 13 Hz, HC-8’a), 2.19 (1H, m, HC-1’), 1.93 
(1H, m, HC-1’), 1.93 (3H, s, H3CC-4’), 1.80 (3H, s, H3CC-7’), 1.35 (3H, s, 
H3CC-4’a).  
 
13C NMR (125 MHz, CDCl3) δ: 200.0 (s, C-5), 166.4 (s, C-16), 153.6 (s, 
C-3), 138.7 (s, C-7), 132.0 (s, Ar-C), 130.3 (d, Ar-C), 129.1 (d, Ar-C), 129.1 
(d, Ar-C), 128.9 (d, C-8), 127.9 (d, Ar-C), 127.9 (d, Ar-C), 127.5 (d, C-4), 
124.5 (q, C-18), 85.8 (s, C-17), 74.4 (d, C-2), 65.0 (s, C-9), 56.0 (q, O-Me), 
50.1 (s, C-6), 46.3 (d, C-1), 40.8 (t, C-14 / C-15), 39.7 (t, C-14 / C-15), 38.4 
(t, C-10), 22.0 (q, C-13), 20.5 (q, C-12), 20.1 (q, C-11).  
 
LRMS (EI), m/z (relative intensity): 512 ([M]+, 9), 218 (6), 198 (34), 189 
(100), 170 (12), 138 (28), 106 (20).  
 
HRMS m/z calcd. for C25H27F3O4S2: 512.1303; found: 512.1318 (EI).  
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(4a'R,8'R,8a'R)-4',4a',7'-Trimethyl-5'-oxo-4a',5',8',8a'-tetrahydro-1'H- 
spiro[[1,3]dithiolane-2,2'-naphthalene]-8'-yl) 
(S)-3,3,3-trifluoro-2-methoxy-2-phenylpropanoate (326) 
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326 
 
Oxalyl chloride (54 μL, 0.62 mmol) was added to a solution of (S)-(+)-MTPA 
(30 mg, 0.12 mmol) and DMF (9 μL, 0.12 mmol) in hexane (0.5 mL) at room 
temperature. A white precipitate formed immediately. After 0.5 h the mixture 
was filtered and concentrated (water aspirator). A solution of a 10:1 mixture 
of 323 and 324 (6 mg, 0.02 mmol), Et3N (30 μL, 22 mg, 0.21 mmol), and 
DMAP (35 mg, 0.29 mmol) in CHCl3 (0.5 mL) was added to the residue. 
After 10 min, TLC of the mixture revealed complete conversion into the 
diasteromeric Mosher’s esters. 1M HCl was added and the reaction mixture 
was extracted with CH2Cl2 (3x). The combined organic layers were 
concentrated and fractionated by FCC (20% ethyl acetate in hexane) to 
give the titled ester (8.5 mg, 90%). 
 
IR (KBr) νmax (cm-1): 2926, 2856, 1751, 1676, 1445, 1236, 1183, 1022.  
 
1H NMR (500 MHz CDCl3) δ: 7.54 (2H, Ar-H), 7.33~7.37 (3H, Ar-H), 6.30 
(1H, d, J = 5 Hz, HC-8’), 5.75 (1H, s, HC-6’), 5.66 (1H, s, HC-3’), 3.56 (3H, s, 
OMe), 3.21~3.32 (3H, m, HC-4, HC-5), 2.93 (1H, m, HC-4 / HC-5), 2.54 (1H, 
ddd, J = 2, 5.5, 12.5 Hz, HC-8’a), 2.37 (1H, m, HC-1’), 2.00 (1H, dd, J = 
12.5, 12.5 Hz, HC-1’), 1.94 (3H, s, H3CC-4’), 1.70 (3H, s, H3CC-7’), 1.36 
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(3H, s, H3CC-4’a).  
 
13C NMR (125 MHz, CDCl3) δ: 199.9 (s, C-5’), 166.6 (s, C-1), 153.9 (s, 
C-7’), 138.8 (s, C-4’), 132.4 (s, Ar-C), 130.3 (d, Ar-C), 129.0 (d, Ar-C), 129.0 
(d, Ar-C), 128.9 (d, C-3’), 127.8 (d, Ar-C), 127.8 (d, Ar-C), 127.4 (d, C-6’), 
123.7 (q, C-3), 85.0 (s, C-2), 73.7 (d, C-8’), 65.1 (s, C-2), 56.0 (q, O-Me), 
50.1 (s, C-4’a), 46.8 (d, C-8’a), 40.7 (t, C-4 / C-5), 39.8 (t, C-4 / C-5), 38.6 (t, 
C-1’), 22.0 (q, CH3C-4’), 20.5 (q, CH3C-4’a), 19.8 (q, CH3C-7’).  
 
LRMS (EI), m/z (relative intensity): 512 ([M]+, 15), 198 (57), 189 (100), 170 
(21), 138 (46), 106 (34).  
 
HRMS m/z calcd. for C25H27F3O4S2: 512.1303; found: 512.1318 (EI). 
 
 
 
(2aR,3aR,7aR,8aS)-1,2,2a,3a,4,7,7a,8a-Octahydro-2a,7,7a-trimethyl-1-
methylene-5,7-bis[(trimethylsilyl)oxy]-cyclobuta[b]naphthalene-3,8- 
dione (327a) 
(2aR,3aR,7aR,8aS)-1,2,2a,3a,4,7,7a,8a-Octahydro-3a,4,8a-trimethyl-1-
methylene-4,6-bis[(trimethylsilyl)oxy]-cyclobuta[b]naphthalene-3,8- 
dione (327b) 
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327a    327b 
 
A solution of 108 (20.0 g, 52.6 mmol) and excess allene (150 mL) in dry 
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THF (180 mL) was irradiated with a 1200 W mercury vapor lamp in a Pyrex 
vacuum-jacketed water-cooled immersion well while argon was bubbled 
through the solution. The entire apparatus was fitted with a dry ice 
condenser and was immersed in a dry ice–acetone bath that maintained an 
internal temperature of ca. –50 °C. After 12 h, the bath was removed and 
the excess allene was recovered (and was reused) by passing the argon 
effluent through a dry ice condenser and the remaining reaction mixture 
was concentrated to afford the crude photoadducts as oil (22 g). With 
similar experiments, a total of 75 g of 108 was converted to 88 g of 327. The 
1H NMR spectrum of the crude products indicated the presence of a 3:1 
mixture 327a, and 327b, respectively, and closely matched that reported 
previously.50 
 
 
 
(3R,4aR,8aR)-3-(2-Oxopropyl)-2,3,4a,8a-tetrahydro-3,8,8a-trimethyl- 
1,4,6(5H)-naphthalenetrione (330) 
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A solution of mercury perchlorate (8.0 g, 20 mmol) in water (450 mL) was 
added to a stirred solution of a 3:1 mixture of 110 and 109 (10.0 g, 38.7 mol) 
in acetone (150 mL). The reaction mixture was stirred at room temperature 
in the dark. After three days, the mixture was concentrated and 330 
precipitated as a white solid. The mixture was filtered and the filtrate was 
extracted with CH2Cl2 (3x100 mL). The combined organic layers were 
concentrated and the residue was combined with the white precipitate. 
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Trituration with diethyl ether and then acetone gave 330 (5.3 g, 71% based 
on 110). ([α]D27 = -3.7; c = 1.3, CH2Cl2) 
 
IR (KBr) νmax (cm-1): 1709, 1673, 1618.  
 
1H NMR (500 MHz CDCl3) δ: 5.77 (1H, s, HC-7), 3.77 (1H, dd, J = 2.5, 5 
Hz, HC-4a), 3.38 (1H, d, J = 15.5 Hz, HC-1’), 3.20 (1H, d, J = 18.5 Hz, 
HC-2), 3.12 (1H, dd, J = 2.5, 17.5 Hz, HC-5), 2.54 (1H, d, J = 18.5 Hz, 
HC-2), 2.51 (1H, dd, J = 5, 7.5 Hz, HC-5), 2.37 (1H, d, J = 15.5 Hz, HC-1’), 
2.09 (3H, s, H3C-3’), 1.89 (3H, s, H3CC-8), 1.58 (3H, s, H3CC-8a), 0.93 (3H, 
s, H3CC-3).  
 
13C NMR (125 MHz, CDCl3) δ: 211.0 (s, C-4), 209.4 (s, C-1), 207.0 (s, 
C-2’), 195.5 (s, C-6), 158.9 (s, C-8), 128.5 (d, C-7), 53.9 (t, C-1’), 52.5 (s, 
C-8a), 51.8 (d, C-4a), 48.8 (t, C-2), 43.9 (s, C-3), 33.3 (t, C-5), 30.3 (q, C-3’), 
25.3 (q, H3CC-8/8a), 24.7 (q, H3CC-8/8a), 21.0 (q, H3CC-3).  
 
LRMS (EI), m/z (relative intensity): 276 ([M]+, 13), 218 (43), 190 (10), 151 
(13), 123 (100), 79 (19).  
 
HRMS m/z calcd. for C16H20O4: 276.1362; found: 276.1366 (EI). 
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(2R,4aR,7R,8aR)-7-hydroxy-2,4a,5-Trimethyl-2-(2-oxopropyl)-2,3,8,8a- 
tetrahydronaphthalene-1,4(4aH,7H)-dione (331) 
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0.1 M aq. NaOH was added dropwise to a stirred solution of crude 340 (5.4 
g) in THF (50 mL). After addition of ca. 1 equivalent (14 mL, 14 mmol) a 
color change from redish to yellow was noted (pH = 9). The reaction mixture 
was neutralized to pH = 7 by addition of AcOH and then was concentrated. 
Fractionation of the residue by FCC (40% ethyl acetate in hexane) gave 
331 (3.3 g, 82% from 339). ([α]D27 = +30; c = 0.9, CH2Cl2) 
 
IR (KBr) νmax (cm-1): 3473, 1697, 1672, 1617.  
 
1H NMR (500 MHz CDCl3) δ: 5.45 (1H, s, HC-6), 4.38 (1H, m, HC-7), 3.27 
(1H, dd, J = 4, 4Hz, HC-8a), 3.21 (1H, d, J = 15Hz, HC-1’), 3.17 (1H, d, J = 
18.5Hz, HC-3), 2.65 (1H, ddd, J = 4, 6, 13Hz, HC-8), 2.44 (1H, d, J = 
18.5Hz, HC-3), 2.29 (1H, d, J = 15Hz, HC-11), 2.10 (3H, s, CH3C-3’), 1.69 
(3H, t, J = 1.5Hz, H3C-C5), 1.64 (1H, ddd, J = 4, 9, 13Hz, HC-8), 1.49 (3H, s, 
CH3C-4a), 0.97 (3H, s, CH3C-2).  
 
13C NMR (125 MHz, CDCl3) δ: 212.4, 211.0, 206.9, 137.8, 128.7, 64.0, 
53.6, 52.8, 52.0, 48.4, 45.1, 30.3, 28.9, 25.5, 25.4, 20.4.  
 
LRMS (EI), m/z (relative intensity): 278 ([M]+, 19), 260 (13), 220 (68), 202 
(50), 177 (29), 151 (11), 138 (16), 123 (100), 109 (39), 91 (20).  
 
HRMS m/z calcd. for C20H22O4: 278.1518; found: 278.1516 (EI). 
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(2R,4aR,7S,8aR)-7-Hydroxy-2,4a,5-trimethyl-2-(2-oxopropyl)-2,3,8,8a- 
tetrahydronaphthalene-1,4(4aH,7H)-dione (332) 
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DIBAL-H reduction of 328 as described for the preparation of 339 but 
quenching with water instead of MeOH gave 332 after fractionation by FCC 
(30% ethyl acetate in hexane). 
  
1H NMR (500 MHz CDCl3) δ: 5.92† (1H, d, J = 6 Hz, HC-7), 5.90‡ (1H, d, J 
= 6 Hz, HC-7), 5.54* (1H, m, HC-6), 4.45‡ (1H, dd, J = 6, 6 Hz, HC-8), 4.43† 
(1H, dd, J = 6, 6 Hz, HC-8), 4.0* (1H, m, HC-7), 3.41* (1H, dd, J = 4, 4 Hz, 
HC-9a), 3.10* (1H, d, J = 15 Hz, HC-1’), 3.08* (1H, d, J = 18.5 Hz, HC-3), 
2.79† (1H, d, J = 5 Hz, HC-9a), 2.55* (1H, d, J = 18.5 Hz, HC-3), 2.55† (1H, 
d, J = 14 Hz, HC-4), 2.47† (1H, d, J = 14 Hz, HC-4), 2.41* (1H, m, HC-8), 
2.32* (1H, d, J = 15 Hz, HC-1’), 2.30† (1H, m, HC-9), 2.12* (1H, ddd, J = 4, 
7.5, 7.5 Hz, HC-8), 2.08* (3H, s, H3C-3’), 2.01† (1H, d, J = 13.5 Hz, HC-3), 
1.92† (1H, d, J = 13.5 Hz, HC-3), 1.88† (1H, m, HC-9), 1.61* (3H, d, J = 1.5 
Hz, H3CC-5), 1.54† (3H, s, H3CC-5a), 1.49‡ (3H, d, J = 1.5 Hz, H3CC-5), 
1.47† (3H, d, J = 1.5 Hz, H3CC-5), 1.40‡ (3H, s, H3CC-5a), 1.31* (3H, s, 
H3CC-4a), 1.30‡ (3H, s, H3CC-2), 1.18† (3H, s, H3CC-2), 1.16‡ (3H, s, 
H3CC-3a), 1.13† (3H, s, H3CC-3a), 0.98* (3H, s, H3CC-2).  
 
13C NMR (125 MHz, CDCl3) δ: 216.7* (s, C-1), 212.4†‡ (s, C-5), 210.7* (s, 
C-4), 206.8* (s, C-2’), 138.6† (s, C-6), 138.4‡ (s, C-6), 135.9* (s, C-5), 
129.5† (d, C-7), 129.3‡ (d, C-7), 129.0* (d, C-6), 115.4‡ (s, C-9b), 114.6† (s, 
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C-9b), 102.5‡ (s, C-2), 101.4† (s, C-2), 72.9‡ (d, C-8), 72.4† (d, C-8), 62.5* 
(d, C-7), 54.6* (s, C-4a), 54.1‡ (s, C-4a), 54.0* (t, C-1’), 53.1‡ (d, C-8), 52.8† 
(s, C-5a), 52.4† (d, C-9a), 51.3‡ (t, C-4), 50.6* (d, C-8a), 49.8† (t, C-4), 
49.7* (t, C-3), 49.1‡ (t, C-3), 47.7† (t, C-3), 47.0† (s, C-3a), 46.2‡ (s, C-3a), 
45.6* (s, C-2), 31.4‡ (t, C-7), 31.1† (t, C-7), 30.48* (q, C-3’), 30.46† (q, 
CH3C-5a), 29.7‡ (q, CH3C-5a), 27.1* (t, C-8), 25.55* (q, CH3C-5a), 25.52‡ 
(q, CH3C-2), 25.1† (q, CH3C-2), 24.4* (q, CH3C-2), 20.38* (q, CH3C-6), 
20.35‡ (q, CH3C-2), 20.2† (q, CH3C-2), 18.20‡ (q, CH3C-6), 18.16† (q, 
CH3C-6). 
 
 
 
(2aS,4aR,7a1S,8aS)-2,2a,4a-Trimethyl-4a,5,8,8a-tetrahydrocyclopropa 
[j]-as-indacene-3,6(2aH,4H)-dione (335) 
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To a solution of 336 (20 mg, 0.068 mmol) in THF (5 mL) was added a 
solution of aq. KOH (1 M;1 mL, 1 mmol) in MeOH (5 mL). The mixture was 
heated under reflux for 45 min, and after cooling, was neutralized by 
addition of citric acid. The reaction mixture was concentrated to remove 
THF and MeOH and then extracted with DCM. The combined organic 
layers were concentrated and fractionated by FCC (30% ethyl acetate in 
hexane) to give 335 (12 mg, 75 %). 
 
IR (KBr) νmax (cm-1): 2963, 1705, 1610, 1455, 1270, 1216.  
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1H NMR (500 MHz CDCl3) δ: 5.79 (1H, s, HC-7), 5.72 (1H, m, HC-1), 2.81 
(1H, d, J = 4 Hz, HC-5), 2.57 (1H, d, J = 4 Hz, HC-5), 2.42 (2H, s, H2C-4), 
2.05 (1H, m, HC-8a), 1.89 (3H, s, CH3C-2), 1.45 (1H, dd, J = 4.5, 7.5 Hz, 
HC-8), 1.29 (3H, s, CH3C-8a), 1.21 (3H, s, CH3C-4a), 0.62 (1H, dd, J = 4, 
4.5 Hz, HC-8).  
 
13C NMR (125 MHz, CDCl3) δ: 211.3, 206.5, 185.0, 142.6, 129.3, 125.1, 
63.0, 51.3, 50.5, 45.5, 37.1, 34.6, 27.3, 22.1, 21.5, 15.2. 
 
LRMS (EI), m/z (relative intensity): 242 ([M]+, 34), 227 (50), 213 (41), 199 
(100), 185 (83), 172 (36), 157 (58), 130 (61). 
 
HRMS m/z calcd. for C16H18O2: 242.1307; found: 242.1307 (EI). 
 
 
 
 
(2R,4aR,7S,8aR)-7-Chloro-2,4a,5-trimethyl-2-(2-oxopropyl)-2,3,8,8a- 
tetrahydronaphthalene-1,4(4aH,7H)-dione (336) 
1
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DIBAL-H reduction of 328 as described for the preparation of 339 but 
quenching with 6 M aq. HCl instead of MeOH gave 336 after fractionation 
by FCC (30% ethyl acetate in hexane). 
 
IR (KBr) νmax (cm-1): 2975, 1711, 1448, 1359, 1210.  
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1H NMR (500 MHz CDCl3) δ: 5.51 (1H, s, HC-6), 4.74 (1H, m, HC-7), 3.36 
(1H, dd, J = 4, 4Hz, HC-8a), 3.26 (1H, d, J = 15Hz, HC-1’), 3.20 (1H, d, J = 
18.5Hz, HC-3), 2.83 (1H, ddd, J = 4, 7, 13.5Hz, HC-8), 2.48 (1H, d, J = 
18.5Hz, HC-3), 2.29 (1H, d, J = 15Hz, HC-1’), 2.12 (3H, s, CH3C-2’), 2.05 
(1H, ddd, J = 4, 9, 13.5Hz, CH3C-5), 1.72 (3H, t, J = 1.5Hz, HC-8), 1.56 (3H, 
s, CH3C-4a), 0.97 (3H, s, CH3C-2).  
 
13C NMR (125 MHz, CDCl3) δ: 212.0 (s, C1), 210.7 (s, C4), 207.0 (s, C2’), 
138.8 (s, C5), 126.9 (d, C6), 72.0 (d, C7), 54.2 (t, C1’), 53.8 (d, C8a), 51.7 
(s, C4a), 48.6 (t, C3), 45.1 (s, C2), 30.4 (q, CH3C-2’), 30.0 (t, C8), 25.7 (q, 
CH3C-5), 25.5 (q, CH3C-2), 20.7 (q, CH3C-4a).  
 
LRMS (EI), m/z (relative intensity): 296 ([M]+, 7), 261 (8), 202 (100), 175 
(12), 133 (24), 107 (77), 91 (50).  
 
HRMS m/z calcd. for C16H21O3Cl: 296.1179; found: 296.1176 (EI). 
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(3aS,5aR,9aR)-8,9b-Epoxy-2-methoxy-2,3a,5a,6-tetramethyl-2,3,3a,4,8,
9,9a,9b-octahydronaphtho[1,2-b]furan-5(5aH)-one (339) 
 
O
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83
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         339 
 
To a solution of tetraone 330 (4.0 g, 14.5 mmol) in THF (400 mL) was 
added 0.5 M 9-BBN (40 mL, 20 mmol) at -10 oC. The reaction mixture was 
kept at -10 oC and was monitored by TLC. After 3 h, 330 was no longer 
present. The mixture was quenched by addition of MeOH (100 mL) and 
then concentrated, and fractionated by FCC (20% ethyl acetate in hexane) 
to give 339 as a colorless oil (4.0 g, 94%). 
   
 
IR (KBr) νmax (cm-1): 1717.  
 
1H NMR (300 MHz CDCl3) δ: 5.96 (1H, dd, J = 1.5, 5.5 Hz, HC-7), 4.47 
(1H, dd, J = 5.5, 5.5 Hz, HC-8), 3.22 (3H, s, H3CO), 2.68 (1H, d, J = 4.5 Hz, 
HC-9a), 2.35 (1H, ddd, J = 5, 5.5, 10.5 Hz, HC-9), 2.01 (1H, d, J = 13.5 Hz, 
HC-3), 1.93 (1H, d, J = 13.5 Hz, HC-3), 1.92 (1H, d, J = 18.5 Hz, HC-4), 
1.89 (1H, d, J = 18.5 Hz, HC-4), 1.64 (1H, m, HC-9), 1.49 (1H, d, J = 1.5 Hz, 
H3CC-6), 1.46 (3H, s, H3CC-5a), 1.20 (3H, s, H3CC-2), 1.17 (3H, s, 
H3CC-3a).  
 
 
NOTE: The compound name is according to the Chemical Abstracts 
skeleton shown on the left.  
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13C NMR (75 MHz, CDCl3) δ: 212.2 (s, C-5), 138.6 (s, C-6), 129.6 (d, C-7), 
114.5 (s, C-9b), 103.8 (s, C-2), 72.2 (d, C-8), 54.7 (s, C-5a), 51.9 (q, H3CO), 
50.9 (t, C-4), 49.4 (d, C-9a), 47.4 (t, C-3), 46.6 (s, C-3a), 31.2 (t, C-9), 25.2 
(q, H3CC-6), 24.1 (q, H3CC-3a), 20.0 (q, H3CC-5a), 18.2 (q, H3CC-2). 
 
 LRMS (EI), m/z (relative intensity): 292 ([M]+, 22), 277 (17), 260 (100), 245 
(17), 232 (7), 220 (30), 202 (31), 185 (71).  
 
HRMS m/z calcd. for C17H24O4: 292.1675; found: 292.1675 (EI). 
 
 
 
 
(2R,4aR,7R,8aR)-4,4a,7-Trimethyl-5,8-dioxo-7-(2-oxopropyl)-1,2,4a,5,6,
7,8,8a-octahydronaphthalen-2-yl 2,2,2-trifluoroacetate (340) 
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340 
 
To 339 (4.0 g, 13.7 mmol) was added a solution of TFA (3.35 mL, 4.96 g, 
43.5 mmol) in DCM (600 mL) at room temperature. After 3 h, the reaction 
mixture was concentrated to give 340 (5.4 g) as yellow oil, which was used 
for the next step without further purification.  
 
IR (KBr) νmax (cm-1): 1783, 1711.  
 
1H NMR (500 MHz CDCl3) δ: 5.68 (1H, m, HC-2), 5.41 (1H, brs, HC-3), 
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3.46 (1H, d, J = 4 Hz, HC-8a), 3.31 (1H, d, J = 15 Hz, HC-1’), 3.23 (1H, d, J 
= 18.5 Hz, HC-6), 2.78 (1H, ddd, J = 4, 6.5, 12 Hz, HC-1), 2.51 (1H, d, J = 
18.5 Hz, HC-6), 2.31 (1H, d, J = 15 Hz, HC-1”), 2.13 (3H, s, H3C-3”), 1.77 
(3H, d, J = 1.5 Hz, CH3C-4), 1.56 (3H, s, CH3C-4a), 0.98 (3H, s, CH3C-7).  
 
13C NMR (125 MHz, CDCl3) δ: 212.0, 210, 207.5, 157.5, 142.4, 129.8, 
121.6, 72.6, 53.9, 52.5, 51.7, 48.5, 44.8, 30.3, 25.7, 25.6, 24.3, 20.8. 
 
 LRMS (EI), m/z (relative intensity): 374 ([M]+, 6), 261 (7), 202 (100), 133 
(11), 107 (72).  
 
HRMS m/z calcd. for C18H21O5F3: 374.1341; found: 374.1345 (EI). 
 
 
 
 
(3aR,5aR,8R,9aS)-3a,4,5a,8,9,9a-Hexahydro-8-hydroxy-3a,5a,6- 
trimethyl-2H-benz[e]indene-2,5(3H)-dione (341) 
(3aR,5aR,8R,9aR)-3a,4,5a,8,9,9a-Hexahydro-8-hydroxy-3a,5a,6- 
trimethyl-2H-benz[e]indene-2,5(3H)-dione (342) 
 
OH
O
H
O
1
2
3
4
9
5
6
7
89a
5a
9b
3a
OH
O
H
O
1
2
3
4
9
5
6
7
89a
5a
9b
3a
 
      341     342 
 
To a stirred solution of 331 (3.3 g, 13 mmol) in THF (600 mL) and MeOH 
(600 mL) was added in 1 M aq. KOH (95 mL, 95 mmol). The mixture was 
heated under reflux for 45 min, and, after cooling, was neutralized by 
addition of citric acid. The reaction mixture was concentrated to remove the 
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THF and MeOH and was extracted with DCM. The combined organic layers 
were fractionated by FCC (70% ethyl acetate in hexane) to give a 1:1 
mixture of 341 and 342 (2.73 g, 88%). Pure samples of 341 and 342 were 
obtained by fractionation of the mixture by FCC (30%-60% ethyl acetate in 
hexane). 
 
 
Data for 341 
 
IR (KBr) νmax (cm-1): 3456, 3383, 1699, 1617.  
 
1H NMR (500 MHz CDCl3) δ: 6.14 (1H, s, HC-1), 5.80 (1H, d, J = 5.5 Hz, 
HC-7), 4.21 (1H, m, HC-8), 3.46 (1H, dd, J = 3, 14 Hz, HC-9a), 2.89 (1H, d, 
J = 12.5 Hz, HC-4), 2.53 (1H, d, J = 18.0 Hz, HC-3), 2.44 (1H, d, J = 12.5 
Hz, HC-4), 2.42 (1H, d, J = 18.0 Hz, HC-3), 1.90 (1H, ddd, J = 3.5, 14, 14 
Hz, HC-9), 1.82 (1H, m, HC-9), 1.77 (3H, s, CH3C-6), 1.38 (3H, s, CH3C-5a), 
1.53 (3H, s, CH3C-3a).  
 
13C NMR (125 MHz, CDCl3) δ: 210.5, 206.2, 183.6, 140.7, 131.8, 125.9, 
62.7, 54.6, 53.5, 50.1, 48.0, 45.0, 34.6, 28.9, 24.1, 20.5.  
 
LRMS (EI), m/z (relative intensity): 260 ([M]+, 74), 245 (51), 217 (13), 203 
(24), 177 (44), 146 (11), 123 (35), 109 (100), 84 (39).  
 
HRMS m/z calcd. for C16H20O3: 260.1412; found: 260.1410 (EI). 
 
 
Data for 342 
 
IR (KBr) νmax (cm-1): 3444, 3433, 3382, 1700, 1694, 1621.  
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1H NMR (500 MHz CDCl3) 5.99 (1H, d, J = 1.5 Hz, HC-1), 5.47 (1H, m, 
HC-7), 4.41 (1H, m, HC-8), 2.87 (1H, d, J = 12.5 Hz, HC-4), 2.86 (1H, ddd, J 
= 1.5, 1.5, 12.5 Hz, HC-9a), 2.47 (1H, s, HC-3), 2.46 (1H, s, HC-3), 2.42 
(1H, d, J = 12.5 Hz, HC-4), 2.21 (1H, dddd, J = 1.5, 1.5, 5.5, 12.5 Hz, HC-9), 
1.87 (3H, dd, J = 1.5, 1.5 Hz, CH3C-6), 1.82 (1H, ddd, J = 10, 12.5, 12.5 Hz, 
CH3C-9), 1.28 (3H, s, CH3C-5a), 1.26 (3H, s, CH3C-3a).  
 
13C NMR (125 MHz, CDCl3) δ: 210.4, 206.6, 183.5, 139.5, 128.8, 127.7, 
66.9, 53.8, 52.1, 50.7, 45.0, 42.3, 29.6, 27.2, 19.7, 19.6.  
 
LRMS (EI), m/z (relative intensity): 260 ([M]+, 80), 245 (100), 203 (33), 202 
(68), 177 (34), 123 (25), 109 (71), 84 (84).  
 
HRMS m/z calcd. for C16H20O3: 260.1412; found: 260.1409 (EI). 
 
 
 
 
(3aS,5R,5aR,8S,9aS)-3,3a,4,5,5a,8,9,9a-Octahydro-5,8-dihydroxy- 
3a,5a,6-trimethyl-2H-benz[e]inden-2-one (343) 
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        343 
 
NaBH4 (400 mg, 10.6 mmol) was added to a solution of a 1:1 mixture of 341 
and 342 (2.37 g, 9.04 mmol) in 1:1 DCM–MeOH (150 mL) at –78 °C. After 
standing at –78 °C for 5 h, acetic acid (5 mL) was added with stirring and 
the reaction mixture was allowed to warm to room temperature. 
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Concentration from toluene (×2) provided a 1:1 mixture of 343 and 115 
(2.16 g, 91%). The crude alcohols were used in the next step without further 
purification. A pure sample of 343, obtained by fractionation of the mixture 
by MPC (50% ethyl acetate in hexane), gave a 1H NMR spectrum that 
closely matched the previously reported data.50 
 
 
 
(3aR,5aS,6S,8R,9S,10aS)-3-Iodo-8-(benzoyloxy)-3a,4,5,5a,6,7,8,9,10, 
10a-decahydro-6-methoxy-3a,5a-dimethyl-6,9-epoxycyclohept[e]inden
-2(3H)-one (356) and 
(3aR,5aS,6S,8R,9S,10aS)-1,1a,3-Triiodo,8-(benzoyloxy)-3a,4,5,5a,6,7,8,
9,10,10a-decahydro-6-methoxy-3a,5a-dimethyl-6,9-epoxycyclohept[e] 
inden-2(3H)-one (358) 
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356    358 
 
To a solution of 103 (5 mg, 0.02 mmol), I2 (8.8 mg, 0.035 mmol) and 
pyridine (12.5 μL, 12.3 mg, 0.15 mmol) in CCl4 (12.5 μL) was added TMSN3  
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(30 μL, 26 mg, 0.22 mmol). The reaction mixture was allowed to stand at 
room temperature for two weeks, then 10% Na2S2O3 aq was added, the 
mixture was extracted with DCM, concentrated and purified with MPC to 
give 358 (1.7 mg, 26%) and 356 (0.5 mg, 5%). 
 
Data for 356 
 
1H NMR (500 MHz CDCl3) δ: 7.4~8.1 (5H, Ar-H), 5.26 (1H, d, J = 7.5 Hz, 
HC-12), 4.54 (1H, brs, HC-11), 3.39 (3H, s, HC-15), 3.11 (1H, , HC-5), 2.92 
(1H, ddd, J = 3.5, 13.5, 13.5 Hz, HC-10), 2.75 (1H, dd, J = 3.5, 13.5 Hz, 
HC-10), 2.59 (1H, dd, J = 7.5, 15 Hz, HC-13), 2.48 (1H, d, J = 18.5 Hz, 
HC-1), 2.37 (1H, d, J = 18.5 Hz, HC-1), 2.15 (1H, m, HC-13), 1.5~1.9 (4H, 
m, H2C-7, H2C-8), 1.33 (3H, s, H3C-17), 1.01 (3H, s, H3C-16).  
 
 LRMS (EI), m/z (relative intensity): 522 ([M]+, 6), 288 (100), 234 (32), 105 
(100).  
 
HRMS m/z calcd. for C24H27IO5: 522.0904; found: 522.0909 (EI). 
 
 
 
Data for 358 
 
1H NMR (500 MHz CDCl3) δ: 5.31 (1H, dd, J = 5.5, 8 Hz, HC-12), 4.61 (1H, 
brs, HC-11), 3.43 (3H, s, HC-15), 3.02 (1H, ddd, J = 4, 13.5, 13.5 Hz, 
HC-10), 2.91 (1H, dd, J = 4, 13.5 Hz, HC-5), 2.60 (1H, dd, J = 7.5, 15.5 Hz, 
HC-13), 2.22 (1H, m, HC-13), 2.03 (1H, ddd, J = 2, 4, 13.5 Hz, HC-10), 
1.7~2.0 (4H, m, H2C-7, 8), 1.44 (3H, s, H3C-17), 1.07 (3H, s, H3C-16).  
 
13C NMR (125 MHz, CDCl3) δ: 196.5 (s, C-2), 181.5 (s, C-4), 166.8 (s, 
C-18), 133.8 (d, Ar-C), 130.1 (d, Ar-C), 130.1 (d, Ar-C), 129.2 (s, Ar-C), 
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128.9 (d, Ar-C), 128.9 (d, Ar-C), 111.1 (s, C-14), 101.1 (s, C-3), 78.6 (d, 
C-11), 77.1 (d, C-12), 49.8 (q, C-15), 52.4 (s, C-9), 46.2 (s, C-6), 41.7 (d, 
C-5), 32.5 (t, C-13), 30.1 (s, C-1), 29.6 (t, C-8), 28.2 (t, C-10), 27.6 (t, C-7), 
21.1 (q, C-17), 12.5 (q, C-16). 
 
 
 
 
 
(3aR,5aS,6S,8R,9S,10aS)-3a,4,5,5a,6,7,8,9,10,10a-Decahydro-8-hydrox
y-6-methoxy-3a,5a-dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e] 
inden-2(3H)-one (370) 
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370 
 
Aqueous NaOH (1 M, 1.2 mL) was added to a solution of 141 (28 mg, 0.064 
mmol) in MeOH (10 mL) and the mixture was heated under reflux. After 10 
h, the mixture was diluted with CH2Cl2, washed with satd. NaHCO3, dried 
over Na2SO4, concentrated to give 370 (18 mg, 84%), which was 
homogeneous by 1H NMR and was used in the next step without further 
purification. ([α]D27 = -48; c = 2.9, CH2Cl2) 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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IR (KBr) νmax (cm-1): 3429, 1696, 1616.  
 
1H NMR (500 MHz CDCl3) δ: 4.28 (1H, m, HC-12), 4.23 (1H, s, HC-11), 
3.39 (3H, s, H3C-15), 2.97 (1H, qq, J = 7, 7 Hz, H3C-18), 2.60 (1H, dd, J = 
3.5, 13 Hz, HC-5), 2.50 (1H, dd, J = 7, 14.5 Hz, HC-13), 2.34 (1H, ddd, J = 
3.5, 13, 13 Hz, HC-10), 2.22 (1H, d, J = 18.5 Hz, HC-1), 2.15 (1H, d, J = 
18.5 Hz, HC-1), 1.90 (1H, m, HC-13), 1.80 (1H, m, HC-7/8), 1.70 (1H, ddd, 
J = 2, 4, 13 Hz, HC-10), 1.40~1.60 (3H, m, H2C-7/8), 1.24 (3H, s, 
H3C-16/17), 1.22 (3H, d, J = 7 Hz, H3C-19/20), 1.21 (3H, d, J = 7 Hz, 
H3C-19/20), 0.99 (3H, s, H3C-16/17).  
 
13C NMR (125 MHz, CDCl3) δ: 208.4, 173.3, 143.8, 111.2, 81.8, 75.2, 
52.6, 49.2, 45.4, 40.1, 39.2, 36.4, 35.4, 28.3, 27.7, 26.5, 26.1, 20.4, 20.1, 
12.1.  
 
LRMS (EI), m/z (relative intensity): 334 ([M]+, 14), 307 (10), 204 (100), 189 
(40), 176 (21), 162 (22), 149 (15).  
 
HRMS m/z calcd. for C20H30O4: 334.2144; found: 334.2137 (EI). 
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(3aR,5aS,6S,9S,10aS)-3a,4,5,5a,6,7,8,9,10,10a-Decahydro-6-methoxy- 
3a,5a-dimethyl-1-(1-methylethyl)-8-oxo-6,9-epoxycyclohept[e]inden-2-
yl trifluoromethanesulfonate (371) 
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371 
 
A solution of Tf2O in CH2Cl2 (0.5 M, 0.18 mL, 0.09 mmol) was added to a 
stirred solution of 2,4,6-tri-tert-butylpyrimidine (25 mg, 0.10 mmol) and 102 
(16 mg, 0.048 mmol) in CH2Cl2 (4 mL) under argon and the mixture was 
heated under reflux. After 2 h, the mixture was concentrated and the 
residue taken up in pentane and filtered. The combined filtrate and 
washings were concentrated and fractionated by FCC (10% ethyl acetate in 
hexane) to give the enol triflate 371 (16 mg, 72%).  
 
1H NMR (500 MHz CDCl3) δ: 6.12 (1H, s, HC-1), 4.34 (1H, br s, HC-11), 
3.42 (3H, s, H3C-15), 3.06 (1H, qq, J = 7 Hz, HC-18), 2.78 (1H, d, J = 18.5 
Hz, HC-13), 2.57 (1H, d, J = 18.5 Hz, HC-13), 2.52 (1H, dd, J = 3, 13.5 Hz, 
HC-5), 2.42 (1H, ddd, J = 3, 12, 13.5 Hz, HC-10), 1.93 (1H, ddd, J = 3, 3, 12 
Hz, HC-10), 1.79 (1H, m, HC-8), 1.54 (1H, m, HC-7), 1.42 (1H, ddd, J = 3.5, 
13, 13 Hz, HC-8), 1.32 (1H, ddd, J = 4, 13, 13 Hz, HC-7), 1.22 (3H, d, J = 7 
Hz, H3C-19), 1.16 (3H, d, J = 7 Hz, H3C-20), 1.06 (3H, s, H3C-17), 0.94 (3H, 
s, H3C-16). 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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(3aR,5aS,6S,9S,10aS)-2,3,3a,4,5,5a,6,7,9,10,10a-decahydro-6-methoxy-
3a,5a-dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e]inden- 
8(3aH)-one (372) 
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A suspension of 10% Pd/C (4 mg) and 142 (8 mg, 0.025 mmol) in MeOH (8 
mL) was stirred under H2 (1 atm, 1 std atm = 101.325 kPa). After 1 h, the 
mixture was filtered through Celite and the combined filtrate and washings 
were concentrated to give 372 (7 mg, 88%) ([α]D27 = -58; c = 1.7, CH2Cl2) 
 
IR (KBr) νmax (cm-1): 1763.  
 
1H NMR (500 MHz CDCl3) δ: 4.29 (1H, s, HC-11), 3.40 (3H, s, H3C-15), 
2.88 (1H, qq, J = 7 Hz, HC-18), 2.69 (1H, d, J = 19 Hz, HC-13), 2.52 (1H, d, 
J = 19 Hz, HC-13), 2.34 (1H, m, HC-5), 2.20~2.34 (2H, m, H2C-2), 1.95 (1H, 
m, HC-10), 1.67 (1H, ddd, J = 3.5, 6.5, 12 Hz, HC-10), 1.2~1.65 (6H, m, 
H2C-1, 7, 8), 1.07 (3H, s, H3C-16/17), 1.02 (3H, d, J = 7 Hz, H3C-19/20), 
0.97 (3H, s, H3C-16/17), 0.92 (3H, d, J = 7 Hz, H3C-19/20).  
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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13C NMR (125 MHz, CDCl3) δ: 215.2, 141.5, 135.1, 109.4, 80.9, 49.8, 
48.2, 44.5, 40.1, 39.3, 37.4, 37.2, 30.0, 29.9, 29.2, 26.7, 24.1, 22.7, 21.6, 
12.8.  
 
LRMS (EI), m/z (relative intensity): 318 ([M]+, 23), 303 (7), 190 (100), 175 
(62), 149 (21), 127 (36), 114 (22), 105 (12).  
 
HRMS m/z calcd. for C20H30O3: 318.2195; found: 318.2197 (EI). 
 
 
 
 
(3aR,5aS,6S,9S,10aS)-2,3,3a,4,5,5a,6,9,10,10a-Octahydro-6-methoxy-3
a,5a-dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e]inden-8-yl- 
trifluoromethanesulfonate (373) 
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         373 
 
NaN(TMS)2 (1 M in THF, 0.175 mL, 0.175 mmol) was added to a stirred 
solution of ketone 372 (7 mg, 0.022 mmol) and PhN(Tf)2 (25 mg, 0.07 mmol) 
in THF (2.5 mL) at –78 °C under argon. After 30 min, the reaction was 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
O
1
3
2
4
5 6 7
8
9
10
5a
10a
3a
157 
quenched by addition of water. The mixture was diluted with ethyl acetate, 
washed with brine, dried over Na2SO4, and concentrated, fractionated by 
MPC (5% ethyl acetate in hexane) to give the enol triflate 373 (8.5 mg, 
89%).  
 
1H NMR (500 MHz CDCl3) δ: 6.05 (1H, s, HC-13), 4.73 (1H, m, HC-11), 
3.34 (3H, s, H3C-15), 2.90 (1H, septet, J = 7 Hz, HC-18), 2.53 (1H, m, 
HC-5), 2.20~2.35 (3H, m, H2C-2, HC-10), 2.03 (1H, m, HC-10), 1.20~1.80 
(6H, m, H2C-1, 7, 8), 1.01 (3H, d, J = 7 Hz, H3C-19/20), 0.98 (3H, s, 
H3C-16/17), 0.97 (3H, s, H3C-16/17), 0.92 (3H, d, J = 7 Hz, H3C-19/20). 
 
 
 
 
(3aR,5aS,6S,9S,10aS)-methyl-2,3,3a,4,5,5a,6,9,10,10a-Decahydro-6- 
methoxy-3a,5a-dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e]- 
indene-8-carboxylate (374) 
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Pd(Ph3P)4 (20 mg, 0.018 mmol) and MeOH (0.3 mL) were sequentially 
added to a stirred solution of the triflate 373 (8.5 mg, 0.019 mmol) and 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
O
1
3
2
4
5 6 7
8
9
10
5a
10a
3a
158 
i-Pr2EtN (6 μL, 6 mg, 0.046 mmol) in CO saturated THF (3 mL) at room 
temperature. The mixture was stirred under CO (1 atm, 1 std atm = 101.325 
kPa) for 1 h and then was concentrated and fractionated by MPC (5% ethyl 
acetate in hexane) to give the ester 374 (4.5 mg, 66%). ([α]D27 = -140; c = 
1.0, CH2Cl2)  
 
IR (KBr) νmax (cm-1): 1721.  
 
1H NMR (500 MHz CDCl3) δ: 7.00 (1H, s, HC-13), 4.96 (1H, s, HC-11), 
3.74 (3H, s, H3C-22), 3.26 (3H, s, H3C-15), 2.84 (1H, qq, J = 7 Hz, HC-18), 
2.10~2.25 (4H, m, H2C-2, HC-5, 10 ), 1.70~1.05 (7H, m, H2C-1, 7, 8, 
HC-10), 0.93 (3H, d, J = 7 Hz, H3C-19/20), 0.92 (3H, s, H3C-16/17), 0.85 
(3H, s, H3C-16/17), 0.82 (3H, d, J = 7 Hz, H3C-19/20).  
 
13C NMR (125 MHz, CDCl3) δ: 166.2, 147.8, 140.3, 136.2, 135.6, 114.7, 
79.7, 52.3, 51.7, 48.3, 42.1, 40.2, 39.9, 37.2, 30.7, 28.8, 26.9, 26.5, 24.3, 
22.3, 21.4, 12.1.  
 
LRMS (EI), m/z (relative intensity): 360 ([M]+, 22), 345 (47), 317 (7), 277 
(10), 257 (7), 204 (22), 189 (100), 95 (10), 69 (13).  
 
HRMS m/z calcd. for C22H32O4: 360.2301; found: 360.2306 (EI). 
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(3aR,5aS,6S,9S,10aS),2,3,3a,4,5,5a,6,7,8,9,10,10a-Dodecahydro-6- 
methoxy-3a,5a-dimethyl-1-(1-methylethyl)-6,9-epoxycyclohept[e]- 
indene-8-methanol (Cyathin A3 methyl acetal) (375) 
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DIBAL-H (1.5 M in toluene, 0.15 mL, 0.225 mmol) was added to a stirred 
solution of 374 (8 mg, 0.024 mmol) in dry ether (3 mL) under argon at –20 
°C. After 30 min, the reaction was quenched by addition of MeOH (1 mL). 
After 1 h, the mixture was diluted with ether, washed with brine, dried over 
Na2SO4, concentrated, and fractionated by FCC (60% ethyl acetate in 
hexane) to give 375 (5.8 mg, 74%). ([α]D27 = -150; c = 0.8, MeOH) (lit.3 [α]D 
= -154; c=0.24, MeOH) 
 
IR (KBr) νmax (cm-1): 3320.  
 
 
 
 
 
NOTE: The compound name is according to the Chemical 
Abstracts skeleton shown on the left. Spectral assignments are 
according to the cyathin numbering system as indicated on the 
structure shown above. 
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1H NMR (500 MHz CDCl3) δ: 6.06 (1H, s, HC-13), 4.79 (1H, m, HC-11), 
4.33 (2H, m, H2C-15), 3.31 (3H, s, H3C-21), 2.95 (1H, qq, J = 6.5, 6.5 Hz, 
HC-18), 2.40 (1H, m, HC-5), 2.24 (3H, m, H2C-2, HC-10), 1.8~1.2 (7H, m, 
H2C-1, 7, 8, HC-10), 1.03 (3H, d, J = 6.5 Hz, H3C-19), 1.01 (3H, s, H3C-16), 
0.97 (3H, s, H3C-17), 0.93 (3H, s, J = 6.5 Hz, H3C-20).  
 
13C NMR (125 MHz, CDCl3) δ: 148.4, 139.4, 136.5, 124.4, 114.3, 78.4, 
59.7, 51.1, 48.3, 42.3, 40.2, 40.0, 37.2, 30.3, 28.8, 27.2, 26.5, 24.5, 22.5, 
21.3, 12.0.  
 
LRMS (EI), m/z (relative intensity): 332 ([M]+, 13), 256 (13), 190 (15), 175 
(29), 141 (100), 97 (47), 69 (77).  
 
HRMS m/z calcd. for C21H32O3: 332.2352; found: 332.2339 (EI). 
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